{"meta":{"query_hash":"1b3bd0e125f4","filters":{"venue":"Lupus Science & Medicine"},"cohort_total":81,"direct_labels_cover":0,"predictions_cover":81,"exported":81,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1b3bd0e125f4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Lupus+Science+%26+Medicine"},"results":[{"id":"W1829419621","doi":"10.1136/lupus-2015-000089","title":"Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome","year":2015,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"University of California, San Francisco","keywords":"Medicine; Lupus nephritis; Internal medicine; Renal function; Creatinine; Population; Gastroenterology; Cyclophosphamide; Clinical trial; Systemic lupus erythematosus; Chemotherapy; Disease","score_opus":0.1728171176805279,"score_gpt":0.40052210047716014,"score_spread":0.22770498279663223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829419621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990933,0.0004899803,0.0000809077,0.000060464707,0.00000435977,0.0000059437175,0.00004346902,0.0000032721625,0.00021827444],"genre_scores_gemma":[0.99974984,0.000048622853,0.00004919708,0.000016950637,0.00001409731,0.0000032230205,0.00008123823,0.000001020937,0.000035852994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990268,0.00041062833,0.00011817504,0.00011563872,0.0001808748,0.00014790925],"domain_scores_gemma":[0.9932145,0.0016838916,0.0037321595,0.00018105873,0.00027432732,0.0009140329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013295297,0.00021768344,0.00043880395,0.00033064003,0.00021948619,0.00050289894,0.00023689939,0.00051421794,0.0009080591],"category_scores_gemma":[0.006549446,0.000098528966,0.00035156275,0.00050099276,0.000249743,0.00037943214,0.00021636243,0.0007585385,0.00012621327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010442954,0.00008335589,0.9960406,0.0000101242595,0.00005066738,0.000051082785,0.000013810022,0.00006768512,0.0003071826,0.0000046512578,0.000044196073,0.0022824372],"study_design_scores_gemma":[0.00003877366,0.0007260588,0.9983563,0.000006601308,0.000037404807,0.00030150102,0.000022268689,0.0003013518,0.00013629677,0.0000148509325,0.00005590649,0.0000026854032],"about_ca_topic_score_codex":0.0005207274,"about_ca_topic_score_gemma":0.00064767594,"teacher_disagreement_score":0.0013295297,"about_ca_system_score_codex":0.00023944383,"about_ca_system_score_gemma":0.00033264802,"threshold_uncertainty_score":0.007031262},"labels":[],"label_agreement":null},{"id":"W2042719511","doi":"10.1136/lupus-2014-000031","title":"Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials","year":2014,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"GlaxoSmithKline","keywords":"Medicine; Belimumab; Systemic lupus erythematosus; Post-hoc analysis; Internal medicine; Lupus erythematosus; Quality of life (healthcare); Clinical trial; Blisibimod; Disease; Immunology; Antibody; B-cell activating factor","score_opus":0.09505911883506928,"score_gpt":0.439801885394299,"score_spread":0.3447427665592297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042719511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917828,0.0040393863,0.00069187884,0.00013554198,0.0000612956,0.00041999505,0.0022273723,0.00004564051,0.0005961761],"genre_scores_gemma":[0.9961099,0.00029447433,0.0005032601,0.00008457051,0.00009757129,0.0006019916,0.0018396468,0.000028563582,0.0004401149],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9863809,0.009280074,0.0010319614,0.0013478195,0.0012209949,0.000738316],"domain_scores_gemma":[0.984622,0.008740083,0.0037687456,0.0011688402,0.0009882574,0.00071205944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015103871,0.0011576666,0.0035323899,0.0009504832,0.0003693401,0.0012893934,0.0007776865,0.00065253815,0.003392881],"category_scores_gemma":[0.01101261,0.00037857617,0.0069402256,0.0011936482,0.0004773492,0.0010628632,0.0008712341,0.001360853,0.00027529907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51522595,0.0011839198,0.35588673,0.0016087685,0.09181763,0.00030794734,0.00028554667,0.0019708094,0.0049045486,0.00011678067,0.0029013879,0.02378994],"study_design_scores_gemma":[0.023765013,0.046952914,0.89284015,0.00011670064,0.028189797,0.00040271747,0.0002096051,0.0030726313,0.0018894394,0.00016968223,0.0023118732,0.00007953073],"about_ca_topic_score_codex":0.0005854177,"about_ca_topic_score_gemma":0.0013566389,"teacher_disagreement_score":0.015103871,"about_ca_system_score_codex":0.0005766802,"about_ca_system_score_gemma":0.0008934797,"threshold_uncertainty_score":0.07987791},"labels":[],"label_agreement":null},{"id":"W2119426740","doi":"10.1136/lupus-2015-000087","title":"A highlight from the LUPUS 2014 meeting: eight great ideas","year":2015,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Medicine; Hydroxychloroquine; Systemic lupus erythematosus; Bench to bedside; Inflammasome; Intensive care medicine; Immunology; Disease; Internal medicine; Inflammation; Coronavirus disease 2019 (COVID-19); Medical physics; Infectious disease (medical specialty)","score_opus":0.07438588434467973,"score_gpt":0.38014352512522653,"score_spread":0.3057576407805468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119426740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013678876,0.89519835,0.00019318752,0.043679312,0.058210388,0.000017578677,0.00009778557,0.000035165893,0.0024314884],"genre_scores_gemma":[0.0018809728,0.8677904,0.0006694977,0.061636183,0.054921523,0.000037196656,0.0002982955,0.00003573962,0.012730091],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989506,0.000185661,0.000106113024,0.0001413669,0.00048038276,0.00013583482],"domain_scores_gemma":[0.9970431,0.000698988,0.0002004608,0.000050402832,0.0012551367,0.00075189763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029440357,0.0011359585,0.001313889,0.0022706976,0.0009922831,0.0038334813,0.0011859236,0.0048392396,0.011478294],"category_scores_gemma":[0.0044588703,0.00041502801,0.001178823,0.0020108148,0.0009473455,0.0050759083,0.002560514,0.0064222063,0.00543839],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009573069,0.000030291236,0.000122069956,0.0061937524,0.0000491545,0.00025392117,0.0001440752,0.00006602045,0.0006788404,0.0028522497,0.7843729,0.20514108],"study_design_scores_gemma":[0.000014754086,0.000038479287,0.0002579122,0.0021434706,0.000033036606,0.00039215948,0.00010673941,0.000014419993,0.000069443086,0.000655912,0.99625874,0.000014855163],"about_ca_topic_score_codex":0.0034572869,"about_ca_topic_score_gemma":0.00759357,"teacher_disagreement_score":0.011478294,"about_ca_system_score_codex":0.0022465312,"about_ca_system_score_gemma":0.0048033386,"threshold_uncertainty_score":0.038398743},"labels":[],"label_agreement":null},{"id":"W2161972580","doi":"10.1136/lupus-2015-000085","title":"Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire","year":2015,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cutaneous Lupus Erythematosus; Dermatology; Consensus conference; Family medicine; Systemic lupus erythematosus; Lupus erythematosus; Immunology; Pathology; Disease; Internal medicine","score_opus":0.04294887910763068,"score_gpt":0.3197414064357975,"score_spread":0.27679252732816684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161972580","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28171292,0.007848346,0.354307,0.103216134,0.005462811,0.19451751,0.0050312523,0.00076385087,0.047140248],"genre_scores_gemma":[0.3687339,0.0036426745,0.5147318,0.0107557075,0.0007420798,0.09433692,0.0034610357,0.00016041484,0.0034354073],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8450826,0.10550282,0.032065973,0.0030174586,0.011291393,0.0030397533],"domain_scores_gemma":[0.769288,0.10167414,0.012126108,0.01047989,0.10058337,0.005848495],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23186225,0.0009098614,0.0014606905,0.004431829,0.0021528087,0.0035968223,0.0026158863,0.0028836764,0.0024159797],"category_scores_gemma":[0.19636148,0.0007276249,0.0022779743,0.0031568306,0.0029069039,0.0035027778,0.00708939,0.0051381583,0.000973457],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013449474,0.0030367346,0.105244935,0.013302643,0.00063222746,0.0012154916,0.12712678,0.005040617,0.007929422,0.035526488,0.084296554,0.61530316],"study_design_scores_gemma":[0.002819004,0.009277938,0.2406903,0.023083149,0.0012634604,0.0035247917,0.16110127,0.026694478,0.011273862,0.06787619,0.4511209,0.0012747209],"about_ca_topic_score_codex":0.0025917003,"about_ca_topic_score_gemma":0.0029363658,"teacher_disagreement_score":0.23186225,"about_ca_system_score_codex":0.0057028485,"about_ca_system_score_gemma":0.021821186,"threshold_uncertainty_score":0.9472506},"labels":[],"label_agreement":null},{"id":"W2217177619","doi":"10.1136/lupus-2015-000112","title":"Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders","year":2015,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Mallinckrodt Pharmaceuticals","keywords":"Medicine; Lupus nephritis; Immune system; Renal biopsy; Systemic lupus erythematosus; Biopsy; Internal medicine; Kidney; Nephritis; Urology; Immunology; Disease","score_opus":0.0372304095176661,"score_gpt":0.30414947500933515,"score_spread":0.26691906549166905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217177619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864,0.00038378898,0.00045303456,0.000018340465,0.000002296509,0.0000136817625,0.00013858144,0.0000097203265,0.00034062235],"genre_scores_gemma":[0.99858546,0.00011411284,0.00074547576,0.000025894846,0.000008131113,0.000014719276,0.0003214723,0.000004344235,0.00018047226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976903,0.000058642978,0.000025899048,0.000057493533,0.00004711597,0.00004192136],"domain_scores_gemma":[0.9995763,0.0001271892,0.00013499882,0.000023154173,0.00006629642,0.000072092684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045379435,0.0001815427,0.00034759028,0.00089897565,0.00022044277,0.00041436724,0.00014656078,0.0002959526,0.001452342],"category_scores_gemma":[0.000540035,0.00008353315,0.00023653984,0.00034297467,0.00018659316,0.00020664324,0.00015431526,0.00022734707,0.000292359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022074243,0.000089053705,0.78365415,0.00017410216,0.00008525097,0.00048286427,0.000265899,0.00019354973,0.19358744,0.00005061214,0.00018218208,0.019027537],"study_design_scores_gemma":[0.000019214285,0.00054955273,0.9821016,0.000018728759,0.00005992243,0.0018358012,0.0002124929,0.0005733143,0.0140836,0.0000675512,0.00047106555,0.000007045342],"about_ca_topic_score_codex":0.0002572592,"about_ca_topic_score_gemma":0.00040453067,"teacher_disagreement_score":0.001452342,"about_ca_system_score_codex":0.00014110895,"about_ca_system_score_gemma":0.00008943501,"threshold_uncertainty_score":0.004858613},"labels":[],"label_agreement":null},{"id":"W2292584779","doi":"10.1136/lupus-2015-000131","title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","year":2016,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pacific Centre for Reproductive Medicine; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Lupus anticoagulant; Pregnancy; Systemic lupus erythematosus; Adverse effect; Obstetrics; Intensive care medicine; Internal medicine; Disease; Thrombosis","score_opus":0.026717000287104217,"score_gpt":0.32342659576675314,"score_spread":0.2967095954796489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292584779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952114,0.000789018,0.00031187572,0.00012715792,0.000018222567,0.000073816394,0.001121669,0.000013238856,0.0023336199],"genre_scores_gemma":[0.99798536,0.0001606735,0.00039288893,0.000046185793,0.000052085754,0.00006123842,0.000960529,0.0000052394957,0.0003357871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603695,0.0018739391,0.0004773921,0.0005963769,0.0008089829,0.00020640841],"domain_scores_gemma":[0.9868154,0.0045073633,0.0054750284,0.0014289645,0.0009729008,0.00080031995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009012798,0.0005301302,0.00047851435,0.001418227,0.0004349787,0.0012391898,0.0006030018,0.0004778297,0.0021395506],"category_scores_gemma":[0.02303161,0.00022374444,0.0006424742,0.0010158941,0.00040962096,0.00071142224,0.0011708841,0.0006097668,0.00038568617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008246205,0.00003566246,0.9966936,0.000020158324,0.000070472815,0.00010025744,0.00008186482,0.000045949688,0.00016156345,0.000058216505,0.00014053284,0.0017671573],"study_design_scores_gemma":[0.00010862838,0.00035533615,0.9969843,0.000027987986,0.00008018208,0.00082293677,0.00007156272,0.00027054382,0.00023234135,0.000055768407,0.000985213,0.000005139785],"about_ca_topic_score_codex":0.0010659036,"about_ca_topic_score_gemma":0.000984171,"teacher_disagreement_score":0.009012798,"about_ca_system_score_codex":0.0003028625,"about_ca_system_score_gemma":0.0005461838,"threshold_uncertainty_score":0.04766482},"labels":[],"label_agreement":null},{"id":"W2338625378","doi":"10.1136/lupus-2015-000104","title":"Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study","year":2015,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; Systemic lupus erythematosus; Internal medicine; Dermatology; Immunology; Disease","score_opus":0.02668486590294203,"score_gpt":0.3295404167427251,"score_spread":0.3028555508397831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338625378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950907,0.0025912793,0.00035120643,0.00010982844,0.000024944662,0.0003350329,0.0005411725,0.000039931427,0.000915954],"genre_scores_gemma":[0.99518716,0.0010889332,0.000756942,0.00038988717,0.000107583204,0.00021704029,0.0014189403,0.000010014893,0.00082341855],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99955493,0.00024213563,0.00003228829,0.00006225452,0.000058811303,0.000049536033],"domain_scores_gemma":[0.9990465,0.0002893931,0.00024254275,0.00007883565,0.00008110617,0.00026150374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020031016,0.00053558423,0.0011812032,0.00017697702,0.0001978053,0.0004212314,0.00038569537,0.0006388391,0.0020858136],"category_scores_gemma":[0.001025443,0.0001924839,0.0006326531,0.00017811685,0.0003093483,0.00039193677,0.00012695632,0.0009977667,0.0003996872],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6195788,0.036884002,0.04801835,0.0011475453,0.0021803523,0.00054809055,0.00033462432,0.0021248646,0.06072862,0.00017916992,0.0032646575,0.22501093],"study_design_scores_gemma":[0.28508326,0.59240454,0.108793445,0.00007245932,0.0009094946,0.0010418928,0.00006232287,0.0014783336,0.0062190774,0.00010167455,0.0037961586,0.000037483464],"about_ca_topic_score_codex":0.00026730308,"about_ca_topic_score_gemma":0.00052932533,"teacher_disagreement_score":0.0020858136,"about_ca_system_score_codex":0.00027734102,"about_ca_system_score_gemma":0.00045879744,"threshold_uncertainty_score":0.0105935335},"labels":[],"label_agreement":null},{"id":"W2338949780","doi":"10.1136/lupus-2015-000143","title":"Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort","year":2016,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; University of Calgary; University of Manitoba; Toronto Western Hospital; Centre hospitalier universitaire de Québec; Queen Elizabeth II Health Sciences Centre; Université Laval; Dalhousie University; University of Toronto","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Medicine; Systemic lupus; Systemic lupus erythematosus; Cohort; Systemic disease; Systemic therapy; Intensive care medicine; Dermatology; Internal medicine; Disease","score_opus":0.024156281282343834,"score_gpt":0.32433841580513567,"score_spread":0.30018213452279185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338949780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998276,0.00020112486,0.000049801314,0.000037976373,0.00000907137,0.000012956112,0.00097164273,0.0000041865724,0.00043728467],"genre_scores_gemma":[0.99832064,0.00014488466,0.000054410262,0.000027929502,0.00003289052,0.000019032175,0.0012167201,0.00000300879,0.00018053886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993375,0.000100244615,0.000050352875,0.00021329892,0.00014292501,0.00015563534],"domain_scores_gemma":[0.99813867,0.00020246809,0.0009145027,0.0001674952,0.00015743438,0.00041939123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007960822,0.00030426847,0.0004996434,0.0010340628,0.00060609134,0.0007816543,0.00042430035,0.0005452075,0.0018377447],"category_scores_gemma":[0.0022509154,0.00035850413,0.0005292305,0.0010308842,0.00021050699,0.00062249834,0.0006187234,0.00073041325,0.0002336479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010242733,0.000020425907,0.9989397,0.0000039828683,0.000043689946,0.00016417632,0.00003929574,0.000025644615,0.00013277943,0.000011591886,0.00012233335,0.00039398653],"study_design_scores_gemma":[0.000009038341,0.00006123495,0.999302,0.000004414575,0.000024034944,0.00033781273,0.000059838352,0.00007095362,0.000015769238,0.00000688901,0.0001052816,0.0000027417307],"about_ca_topic_score_codex":0.009596137,"about_ca_topic_score_gemma":0.011994397,"teacher_disagreement_score":0.009596137,"about_ca_system_score_codex":0.00024332889,"about_ca_system_score_gemma":0.00039040804,"threshold_uncertainty_score":0.01908058},"labels":[],"label_agreement":null},{"id":"W2413195052","doi":"10.1136/lupus-2016-000156","title":"Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients","year":2016,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"National Cancer Institute; U.S. Department of Veterans Affairs; U.S. Department of Health and Human Services; U.S. Department of Defense","keywords":"Medicine; Systemic lupus; Incidence (geometry); Lupus nephritis; Internal medicine; Systemic lupus erythematosus; Renal transplant; Immunology; Cancer; Cancer incidence; Oncology; Gastroenterology; Kidney; Disease","score_opus":0.01855696534085218,"score_gpt":0.31581600068574756,"score_spread":0.2972590353448954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413195052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748068,0.012315867,0.0028998624,0.00030803762,0.00016776985,0.000104383784,0.0075973715,0.00017939939,0.0016205213],"genre_scores_gemma":[0.9954892,0.0009741559,0.0005533984,0.00004264747,0.00011326181,0.000050483388,0.0025149882,0.000012940722,0.0002489417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996071,0.0015024372,0.0007065804,0.0007552034,0.0007719456,0.00019276474],"domain_scores_gemma":[0.9859751,0.0048097605,0.006865013,0.0008418178,0.0010105071,0.000497827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053894273,0.0005571059,0.00094358093,0.0031578839,0.00012374228,0.00081974966,0.00072395935,0.00063356,0.0022078047],"category_scores_gemma":[0.017891847,0.00038963952,0.0034930313,0.0023347528,0.00028763403,0.0007901374,0.00067648303,0.0009796111,0.00029750855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061005005,0.000026031234,0.99124944,0.0002382973,0.0029046007,0.00007205016,0.000062645384,0.0004953359,0.00022265493,0.00015724992,0.00043590038,0.0035256888],"study_design_scores_gemma":[0.00006425556,0.00032767846,0.99439573,0.00003186923,0.0009209057,0.0007883466,0.000121589466,0.002262377,0.00017301366,0.00026758446,0.00062368764,0.000022983459],"about_ca_topic_score_codex":0.0018269948,"about_ca_topic_score_gemma":0.0011351169,"teacher_disagreement_score":0.0053894273,"about_ca_system_score_codex":0.0004248577,"about_ca_system_score_gemma":0.00030585533,"threshold_uncertainty_score":0.028502345},"labels":[],"label_agreement":null},{"id":"W2590761296","doi":"10.1136/lupus-2016-000204","title":"Outcomes in mothers with rheumatic diseases and their offspring workshop","year":2017,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université Laval; Mount Sinai Hospital; Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Offspring; Epidemiology; Family medicine; Alternative medicine; Rheumatic disease; Reproductive health; Medical education; Disease; Pregnancy; Environmental health; Pathology; Population","score_opus":0.02618575209802052,"score_gpt":0.32105401003001266,"score_spread":0.2948682579319921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590761296","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06382239,0.021827985,0.0016482858,0.8130417,0.05875711,0.0014059752,0.0039683874,0.00010882853,0.03541927],"genre_scores_gemma":[0.5270837,0.06607637,0.009909986,0.183142,0.070312776,0.009573647,0.005531868,0.0002182842,0.12815148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961279,0.0017328934,0.00012857051,0.00025649354,0.0008139331,0.00094022666],"domain_scores_gemma":[0.99034214,0.0023896198,0.00035826306,0.00017829673,0.0014929116,0.0052387016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015273123,0.0006954445,0.0005715948,0.00065016805,0.0038643347,0.0023873195,0.0011858033,0.0027197707,0.007244867],"category_scores_gemma":[0.014930035,0.00032613188,0.0010907224,0.00035644847,0.0007452012,0.0009890528,0.0051502697,0.0070961197,0.00090176455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071694935,0.0007166766,0.010985291,0.0005853926,0.00017349662,0.0044086515,0.018182239,0.00023818937,0.00088454125,0.0037664,0.8472018,0.112140365],"study_design_scores_gemma":[0.00056615134,0.0008470868,0.034894716,0.0025560542,0.00019270745,0.0013670245,0.03472597,0.00020457785,0.0011522896,0.002548912,0.92076385,0.0001806306],"about_ca_topic_score_codex":0.027864197,"about_ca_topic_score_gemma":0.065153666,"teacher_disagreement_score":0.027864197,"about_ca_system_score_codex":0.0076186606,"about_ca_system_score_gemma":0.012823743,"threshold_uncertainty_score":0.08077294},"labels":[],"label_agreement":null},{"id":"W2596603956","doi":"10.1136/lupus-2016-000176","title":"Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus","year":2017,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Human Genome Research Institute; Genentech; National Institutes of Health; Horizon Pharmaceuticals; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Mallinckrodt Pharmaceuticals; U.S. Department of Veterans Affairs","keywords":"Medicine; Systemic lupus erythematosus; Autoantibody; Internal medicine; Medical record; Immunology; Antibody; Disease","score_opus":0.10235183702937885,"score_gpt":0.3613580658574526,"score_spread":0.2590062288280738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596603956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628985,0.0004589935,0.0006913787,0.000048535003,0.0000073927363,0.00006770419,0.0011982019,0.000023316281,0.0012146538],"genre_scores_gemma":[0.99766684,0.00009730828,0.00070168474,0.000031478357,0.000022713219,0.000031807704,0.0013704004,0.000005191554,0.000072511495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933257,0.0026238614,0.00097622076,0.0013264513,0.0012944422,0.0004533116],"domain_scores_gemma":[0.9756291,0.005265493,0.012369987,0.0036423835,0.0019328381,0.0011602415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006645446,0.00036092036,0.000787062,0.0027732276,0.00063089095,0.0011753719,0.0005728875,0.00031913756,0.0019196393],"category_scores_gemma":[0.017800536,0.0002189198,0.00038318,0.0022428925,0.0004887212,0.0010465937,0.0015534983,0.00037106447,0.000376876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012350817,0.0000139511,0.9962662,0.00001325941,0.000029126988,0.000040890456,0.000061189734,0.000045223078,0.00027808637,0.000026389409,0.00012804539,0.002974129],"study_design_scores_gemma":[0.000010784132,0.00009463344,0.99858534,0.000016710917,0.00003138935,0.00046421762,0.00009425874,0.00024305374,0.0001448714,0.000028302473,0.00028221926,0.000004218494],"about_ca_topic_score_codex":0.0073232953,"about_ca_topic_score_gemma":0.010936973,"teacher_disagreement_score":0.0073232953,"about_ca_system_score_codex":0.00045661093,"about_ca_system_score_gemma":0.00089203403,"threshold_uncertainty_score":0.035144866},"labels":[],"label_agreement":null},{"id":"W2768240243","doi":"10.1136/lupus-2016-000187","title":"Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Calgary; McGill University Health Centre","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Center for Chronic Disease Prevention and Health Promotion; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Human Genome Research Institute; Centre International de Recherche sur le Cancer; World Health Organization; National Cancer Institute; National Center for Advancing Translational Sciences; Foundation for the National Institutes of Health","keywords":"Medicine; Single-nucleotide polymorphism; Systemic lupus erythematosus; Diffuse large B-cell lymphoma; Lymphoma; Genetics; Oncology; Internal medicine; Gene; Disease; Genotype; Biology","score_opus":0.01951631518650422,"score_gpt":0.28820250633308325,"score_spread":0.26868619114657905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768240243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626429,0.034114357,0.0009854077,0.00042023414,0.00005901731,0.000013680757,0.0009638977,0.000050833907,0.0007495975],"genre_scores_gemma":[0.9965779,0.0024850196,0.0002899298,0.00010389347,0.000049940325,0.0000075664557,0.00032012493,0.000005956149,0.00015962307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896634,0.0003767622,0.00013068099,0.00032863472,0.00013147201,0.000066169145],"domain_scores_gemma":[0.9978666,0.0010222761,0.0007301013,0.0001453824,0.00011659132,0.00011908719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001633617,0.00053329545,0.0006879105,0.0007260411,0.00020536316,0.00062481436,0.00037520888,0.0006635025,0.0023715904],"category_scores_gemma":[0.0036998312,0.00022393801,0.0017801067,0.0014314723,0.0002601465,0.0002303371,0.0002954885,0.0005105644,0.00018641763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050428985,0.00011175175,0.94529164,0.0010408594,0.021538425,0.0004879845,0.00006138541,0.0011257062,0.0051373877,0.0001391954,0.00051753136,0.019505147],"study_design_scores_gemma":[0.0007507949,0.0008223056,0.9720296,0.00024440873,0.018500766,0.0015560631,0.0000707192,0.0017112875,0.001741452,0.0005658497,0.0019848745,0.000021909564],"about_ca_topic_score_codex":0.0015429197,"about_ca_topic_score_gemma":0.0016684486,"teacher_disagreement_score":0.0023715904,"about_ca_system_score_codex":0.00021784019,"about_ca_system_score_gemma":0.00024287273,"threshold_uncertainty_score":0.008639455},"labels":[],"label_agreement":null},{"id":"W2778120135","doi":"10.1136/lupus-2017-000240","title":"Repository corticotropin injection in patients with persistently active SLE requiring corticosteroids: post hoc analysis of results from a two-part, 52-week pilot study","year":2017,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Post-hoc analysis; Post hoc; Internal medicine","score_opus":0.03877297198526768,"score_gpt":0.3159745439822459,"score_spread":0.2772015719969782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778120135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889404,0.00033367984,0.00016793764,0.000025521893,0.000015017289,0.0002892797,0.000108974076,0.000015384356,0.00015033332],"genre_scores_gemma":[0.9986137,0.00015113843,0.0003652153,0.000047732843,0.00005897661,0.00028976114,0.00019633184,0.0000060747752,0.00027106015],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984523,0.0009463334,0.00010953664,0.00018742288,0.00013587174,0.00016849079],"domain_scores_gemma":[0.9958561,0.0016518864,0.0011464275,0.00057667855,0.00026126747,0.0005075657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004189194,0.001079667,0.0025368917,0.00030761343,0.00026240665,0.0006107355,0.0005108119,0.00061900064,0.0022174676],"category_scores_gemma":[0.0032453712,0.0003658175,0.0013954997,0.00036391482,0.00079642254,0.0006972243,0.00030699407,0.0010803373,0.0004280613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9244175,0.010860413,0.014994074,0.00037633855,0.0010549217,0.00019419046,0.0002128906,0.0007025055,0.016730586,0.00003163805,0.0002723068,0.030152757],"study_design_scores_gemma":[0.10686778,0.8380896,0.049101375,0.000016854292,0.0009085085,0.00019895523,0.000079341145,0.0008043107,0.0033546602,0.000033902328,0.0005159593,0.00002888845],"about_ca_topic_score_codex":0.00039896733,"about_ca_topic_score_gemma":0.00054750795,"teacher_disagreement_score":0.004189194,"about_ca_system_score_codex":0.00051308714,"about_ca_system_score_gemma":0.0008792208,"threshold_uncertainty_score":0.022154808},"labels":[],"label_agreement":null},{"id":"W2781073107","doi":"10.1136/lupus-2017-000239","title":"Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments","year":2017,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"AstraZeneca","keywords":"Medicine; Disease; Belimumab; B-cell activating factor; Immunology; Clinical trial; Drug development; Immune system; Immune dysregulation; Bioinformatics; Intensive care medicine; Drug; Pharmacology; Internal medicine; B cell; Antibody","score_opus":0.2452857687171864,"score_gpt":0.4797586957284955,"score_spread":0.2344729270113091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781073107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003778733,0.9204909,0.001476726,0.06897301,0.0034738411,0.00004968849,0.00013963606,0.00013055852,0.004887704],"genre_scores_gemma":[0.0024366511,0.9610344,0.0062887203,0.02181679,0.0034013672,0.00016609601,0.00027727627,0.00003728643,0.0045413645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978319,0.0008026536,0.00031424244,0.00020491326,0.0006425566,0.00020369787],"domain_scores_gemma":[0.99453074,0.0028417266,0.00043995096,0.00013949959,0.001368432,0.0006797141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006129917,0.0009027279,0.0019550805,0.0015513441,0.0007528953,0.0033656447,0.001776734,0.0047438284,0.0122404555],"category_scores_gemma":[0.005937038,0.00042862378,0.0013742102,0.0009318477,0.0015078649,0.005471664,0.0017828548,0.009908247,0.005294793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026759622,0.0002577739,0.0003616984,0.0080011515,0.00011671887,0.0005486641,0.00018787246,0.0006827736,0.0013859831,0.015079578,0.24079505,0.7323151],"study_design_scores_gemma":[0.00009623419,0.00021935943,0.00042380817,0.008341349,0.00012096699,0.0006265251,0.00024853882,0.00026281492,0.00020764869,0.013537266,0.97587425,0.00004134641],"about_ca_topic_score_codex":0.0013566919,"about_ca_topic_score_gemma":0.0052242894,"teacher_disagreement_score":0.0122404555,"about_ca_system_score_codex":0.0015222556,"about_ca_system_score_gemma":0.005006634,"threshold_uncertainty_score":0.04094845},"labels":[],"label_agreement":null},{"id":"W2914387295","doi":"10.1136/lupus-2021-000633","title":"Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"UCB Pharma; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Weill Cornell Medical College; National Institutes of Health; Hospital for Special Surgery","keywords":"Medicine; Antiphospholipid syndrome; Pregnancy; Gestation; Live birth; Obstetrics; Clinical trial; Prospective cohort study; Lupus anticoagulant; Gestational age; Pediatrics; Internal medicine; Antibody; Immunology","score_opus":0.1512627088700417,"score_gpt":0.4765680688712584,"score_spread":0.3253053600012167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914387295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95619655,0.0054421853,0.0011653362,0.0006086524,0.00003047011,0.00024809557,0.031993154,0.00007215636,0.004243442],"genre_scores_gemma":[0.9711738,0.0020337016,0.0011551195,0.0002805324,0.000044569024,0.000331782,0.024318233,0.000033926895,0.00062833726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99114335,0.0041459543,0.0018351607,0.00090908393,0.0016441052,0.00032242044],"domain_scores_gemma":[0.9727658,0.008082798,0.014449917,0.001966337,0.00174304,0.0009921036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0085598845,0.00018309438,0.0004492452,0.0014804037,0.00026944885,0.0009365197,0.00041955188,0.00039976207,0.0014062237],"category_scores_gemma":[0.021859141,0.00026946992,0.00042177088,0.003157524,0.00022760342,0.0009202225,0.00089259906,0.00059653516,0.000490925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010276489,0.00007084981,0.98650646,0.00015885815,0.00018367793,0.00010441756,0.00015537546,0.00011977527,0.00013576109,0.00014435867,0.0017555099,0.0096372105],"study_design_scores_gemma":[0.0001870025,0.00044347957,0.9941865,0.00012132842,0.00018930809,0.0008291245,0.00017857796,0.00027753712,0.00033021017,0.0000719131,0.003165462,0.000019572022],"about_ca_topic_score_codex":0.0015250811,"about_ca_topic_score_gemma":0.0016835444,"teacher_disagreement_score":0.0085598845,"about_ca_system_score_codex":0.00047812017,"about_ca_system_score_gemma":0.0008109609,"threshold_uncertainty_score":0.04526955},"labels":[],"label_agreement":null},{"id":"W2944009275","doi":"10.1136/lupus-2019-000324","title":"Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival","year":2019,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Calgary; Jewish General Hospital; BC Cancer Agency; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"BCL6; Medicine; Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Population; Oncology; Internal medicine; Tissue microarray; CD20; Cancer; Pathology; Immunology; B cell; Antibody","score_opus":0.019134157253102472,"score_gpt":0.2884678500807176,"score_spread":0.26933369282761516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944009275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999408,0.0003016635,0.000049340364,0.00001843458,0.0000025255652,0.00000167062,0.000058660113,0.0000022486954,0.00015738253],"genre_scores_gemma":[0.9997373,0.00007283112,0.000029711808,0.0000071264485,0.000009059335,0.0000015419436,0.000100220954,8.7355176e-7,0.000041409683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998047,0.00005200786,0.000027620326,0.000038557067,0.000034491477,0.00004265311],"domain_scores_gemma":[0.99826163,0.00046779765,0.0006814674,0.00007173002,0.00014493098,0.00037237312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005018665,0.00024309468,0.00021238334,0.0007858363,0.00030105605,0.00044722055,0.0001895742,0.00039212382,0.001577112],"category_scores_gemma":[0.0015596672,0.00010182976,0.00025506454,0.0006617807,0.0003033905,0.00029067558,0.00028579764,0.000339471,0.0003333735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014525457,0.000010071219,0.99825746,0.000005306112,0.00001311168,0.00014544117,0.000019657713,0.000024123154,0.00055520947,0.0000047740823,0.000023423232,0.000796243],"study_design_scores_gemma":[0.0000073526085,0.00012340453,0.99688655,0.0000050036015,0.000030774023,0.0023309453,0.000086094966,0.00017009274,0.00016864053,0.000030429976,0.00015820253,0.0000025728493],"about_ca_topic_score_codex":0.00048006585,"about_ca_topic_score_gemma":0.0005031612,"teacher_disagreement_score":0.001577112,"about_ca_system_score_codex":0.00013760685,"about_ca_system_score_gemma":0.00013744608,"threshold_uncertainty_score":0.0052759647},"labels":[],"label_agreement":null},{"id":"W2965165808","doi":"10.1136/lupus-2019-000333","title":"Elevated serum complement levels and higher gene copy number of complement <i>C4B</i> are associated with hypertension and effective response to statin therapy in childhood-onset systemic lupus erythematosus (SLE)","year":2019,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Research Resources; Childhood Arthritis and Rheumatology Research Alliance; National Institutes of Health; Pfizer","keywords":"Medicine; C4A; Internal medicine; Atorvastatin; Placebo; Systemic lupus erythematosus; Statin; Blood pressure; Immunology; Disease; Pathology; Gene","score_opus":0.02662057265280304,"score_gpt":0.3123990133543095,"score_spread":0.28577844070150643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965165808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963653,0.0001175689,0.000096441436,0.000014998542,0.0000010667134,0.0000022490958,0.00005281632,0.0000035213716,0.00007467292],"genre_scores_gemma":[0.99962425,0.000036880178,0.00020558306,0.0000072400503,0.0000037859309,0.0000025344993,0.0000627067,0.0000011787271,0.00005591619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996106,0.00014885163,0.000036365538,0.00007614853,0.0000849713,0.000043105567],"domain_scores_gemma":[0.9982882,0.00059275894,0.00080432364,0.000091240465,0.00006045933,0.00016295446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006699415,0.00026647028,0.00024880943,0.0004216372,0.00016987548,0.00031103336,0.00015340024,0.0002575456,0.0012903025],"category_scores_gemma":[0.0016536893,0.00014523124,0.00021491869,0.0004313025,0.00032051303,0.00014424059,0.00018196346,0.00039096206,0.00008469636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023608012,0.000076768345,0.97984594,0.000024910702,0.000121705605,0.00012737376,0.000038814585,0.00015183429,0.01321969,0.000030546387,0.000048441485,0.0039531193],"study_design_scores_gemma":[0.000026325908,0.0003331916,0.9968039,0.0000031809589,0.00006277589,0.0004820784,0.0000236936,0.0003985941,0.0017677861,0.000026736656,0.000069168236,0.00000260049],"about_ca_topic_score_codex":0.0010306264,"about_ca_topic_score_gemma":0.001114966,"teacher_disagreement_score":0.0012903025,"about_ca_system_score_codex":0.00017404144,"about_ca_system_score_gemma":0.00020061241,"threshold_uncertainty_score":0.004316449},"labels":[],"label_agreement":null},{"id":"W2966476163","doi":"10.1136/lupus-2019-000325","title":"Marital status and age of systemic lupus erythematous diagnosis: the potential for differences related to sex and gender","year":2019,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"McGill University Health Centre; Lupus Research Alliance","keywords":"Medicine; Marital status; Population; Cohort; Demography; Pediatrics; Internal medicine","score_opus":0.023631025216118748,"score_gpt":0.30491048548956,"score_spread":0.28127946027344125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966476163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980653,0.0006658302,0.00012428254,0.000089940935,0.000012009211,0.0000057237335,0.00018739223,0.000001457141,0.0008479363],"genre_scores_gemma":[0.99975556,0.00006923241,0.00002739536,0.000014010715,0.000005403693,0.0000018319769,0.000056293764,7.101987e-7,0.00006954581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924004,0.00031234304,0.00007356446,0.00010276863,0.00013423193,0.00013699864],"domain_scores_gemma":[0.99843866,0.00045896598,0.00065421546,0.00007049065,0.0001529664,0.00022462058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009010762,0.00012830086,0.00021204301,0.0005047871,0.0003668969,0.00039592962,0.00025444443,0.00019764356,0.0026407535],"category_scores_gemma":[0.004047735,0.000103686194,0.0002909609,0.00059462956,0.0002513303,0.000344235,0.0003396068,0.000289865,0.00019456717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041562173,0.0000045176384,0.9989808,0.0000038675175,0.00002026048,0.000026320973,0.00006811099,0.0000077672985,0.00006579005,0.000011417059,0.000025811685,0.00074360275],"study_design_scores_gemma":[0.0000013110906,0.000025900754,0.9995689,0.0000053538192,0.0000073134784,0.00010110089,0.000114293754,0.000060333496,0.000019174227,0.000010565783,0.000084923355,8.5039e-7],"about_ca_topic_score_codex":0.009330746,"about_ca_topic_score_gemma":0.012864528,"teacher_disagreement_score":0.009330746,"about_ca_system_score_codex":0.00024404474,"about_ca_system_score_gemma":0.00025844565,"threshold_uncertainty_score":0.0185529},"labels":[],"label_agreement":null},{"id":"W2982328316","doi":"10.1136/lupus-2019-000344","title":"Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program","year":2019,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; National Center for Chronic Disease Prevention and Health Promotion; School of Medicine, New York University; York University; New York City Department of Health and Mental Hygiene","keywords":"Medicine; Incidence (geometry); Discoid lupus erythematosus; Systemic lupus erythematosus; Population; Dermatology; Lupus nephritis; Lupus erythematosus; Epidemiology; Internal medicine; Environmental health; Immunology; Disease; Antibody","score_opus":0.017635652417770993,"score_gpt":0.3091104129741889,"score_spread":0.2914747605564179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982328316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540916,0.001841815,0.0017638393,0.00020379569,0.000032716984,0.00018770494,0.037563924,0.00013577909,0.004178792],"genre_scores_gemma":[0.96862227,0.0012869446,0.0021614425,0.00009980284,0.000053262505,0.00023693919,0.02634949,0.000010599088,0.0011792824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937254,0.00019520873,0.000099159515,0.00010272327,0.00017902719,0.000051409977],"domain_scores_gemma":[0.9984415,0.00013894703,0.0006226924,0.000080890946,0.00061394006,0.00010201068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010442486,0.00035645664,0.00021648275,0.0025574092,0.00021230256,0.000346296,0.0005731595,0.00016344053,0.0020578376],"category_scores_gemma":[0.0020149902,0.00022199728,0.00030990355,0.0024536604,0.00011616743,0.0002338244,0.00040096047,0.0003031754,0.0005170997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043537653,0.000025127205,0.99114835,0.000087247,0.00017773469,0.000038464994,0.00011661529,0.00027655048,0.00021507622,0.000047567282,0.0027357738,0.0050879633],"study_design_scores_gemma":[0.000014530011,0.00003614932,0.9982729,0.000021908114,0.0000367816,0.00013489225,0.00008644984,0.00028412553,0.00007676882,0.000017387163,0.0010142509,0.00000392856],"about_ca_topic_score_codex":0.06915604,"about_ca_topic_score_gemma":0.06420794,"teacher_disagreement_score":0.06915604,"about_ca_system_score_codex":0.0010292253,"about_ca_system_score_gemma":0.000852245,"threshold_uncertainty_score":0.13750702},"labels":[],"label_agreement":null},{"id":"W3018071643","doi":"10.1136/lupus-2020-000383","title":"Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Placebo; Internal medicine; Double blind; Alternative medicine; Pathology","score_opus":0.0435476210145936,"score_gpt":0.3022930592605447,"score_spread":0.25874543824595114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018071643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491318,0.016667146,0.0015496941,0.00085198565,0.0005470565,0.026278084,0.0025308584,0.00012184232,0.0023215283],"genre_scores_gemma":[0.9658602,0.0046941265,0.0026846146,0.0014823292,0.00069152977,0.020668251,0.0019331087,0.000027908278,0.0019579232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99668616,0.0021188688,0.00025341456,0.00042030774,0.00024262503,0.0002786651],"domain_scores_gemma":[0.997957,0.00070740224,0.0005165631,0.00017189505,0.00016678177,0.00048033075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064582066,0.0020194952,0.004295423,0.000615239,0.0005520689,0.0012606886,0.0008963805,0.0022182781,0.007971944],"category_scores_gemma":[0.0042250124,0.00070362166,0.0024257828,0.0007757106,0.0012271999,0.0010939904,0.00056991767,0.0014770614,0.0011034643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98121095,0.0036506257,0.0011399087,0.0011923234,0.0012480306,0.00005447486,0.000050855633,0.00016755932,0.0019045427,0.000056053555,0.0003614714,0.008963204],"study_design_scores_gemma":[0.93365353,0.06225157,0.0024316313,0.00004454808,0.00079261867,0.000037532565,0.000013435859,0.00013087215,0.00013954712,0.00005543506,0.0004364409,0.000012814878],"about_ca_topic_score_codex":0.00034596687,"about_ca_topic_score_gemma":0.0007247394,"teacher_disagreement_score":0.007971944,"about_ca_system_score_codex":0.00060157815,"about_ca_system_score_gemma":0.001538284,"threshold_uncertainty_score":0.034154654},"labels":[],"label_agreement":null},{"id":"W3037986445","doi":"10.1136/lupus-2019-000373","title":"Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review","year":2020,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"EMD Serono; Pfizer; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Xencor","keywords":"Medicine; Observational study; Quality of life (healthcare); Randomized controlled trial; Convergent validity; Construct validity; MEDLINE; Criterion validity; Content validity; Patient-reported outcome; Face validity; Internal validity; Physical therapy; Clinical psychology; Psychometrics; Internal medicine; Internal consistency; Pathology","score_opus":0.1747285593655969,"score_gpt":0.35345910556422044,"score_spread":0.17873054619862355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037986445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012863555,0.9946683,0.0007784233,0.00038908937,0.00024161182,0.0018467024,0.00048811815,0.00003047165,0.0002709756],"genre_scores_gemma":[0.06625385,0.91344655,0.0058706757,0.0019446559,0.00041829539,0.011110855,0.0007461944,0.000035606005,0.00017331753],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.91034025,0.041475397,0.03412659,0.0042125606,0.009173505,0.00067165727],"domain_scores_gemma":[0.71280175,0.23252365,0.040599246,0.003570901,0.009662968,0.0008415151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06632351,0.0020745676,0.019626243,0.009900298,0.0009346677,0.0047445623,0.0035144612,0.0043822844,0.0050720633],"category_scores_gemma":[0.24904345,0.0014803594,0.016160794,0.008868526,0.0022820008,0.004446395,0.0018724226,0.002626054,0.0003737803],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000990715,0.000032964093,0.0008727331,0.93237877,0.025522182,0.000045404635,0.00009792139,0.00015987355,0.00009796211,0.0003086782,0.0009026712,0.038590234],"study_design_scores_gemma":[0.004571647,0.0008116663,0.0053669875,0.7964591,0.18007974,0.00024142738,0.00020864447,0.00052428484,0.00034773166,0.0011143221,0.010175747,0.00009872845],"about_ca_topic_score_codex":0.0028381785,"about_ca_topic_score_gemma":0.006058067,"teacher_disagreement_score":0.06632351,"about_ca_system_score_codex":0.0060582883,"about_ca_system_score_gemma":0.0111474395,"threshold_uncertainty_score":0.35075647},"labels":[],"label_agreement":null},{"id":"W3092090591","doi":"10.1136/lupus-2020-000412","title":"Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study","year":2020,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital","funders":"GlaxoSmithKline","keywords":"Belimumab; Medicine; Propensity score matching; Post-hoc analysis; Internal medicine; Cohort; Population; Systemic lupus erythematosus; Cohort study; Disease; Immunology","score_opus":0.06820113777116196,"score_gpt":0.3603587394254175,"score_spread":0.2921576016542555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092090591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983181,0.0005196747,0.00052467344,0.00003259252,0.000019932244,0.00012283876,0.00027730022,0.000005890651,0.00017907997],"genre_scores_gemma":[0.9989936,0.000071056835,0.00026634056,0.00003132268,0.000017466296,0.00013156013,0.00036034503,0.0000015686707,0.00012676604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944508,0.0038229043,0.0003789894,0.0006480428,0.00042033926,0.00027888565],"domain_scores_gemma":[0.9901344,0.003791658,0.0030316908,0.0016958087,0.00077309913,0.0005733248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010518362,0.00042120193,0.00077877473,0.00041889527,0.00033236685,0.0005035981,0.00045549453,0.00046882767,0.0014041509],"category_scores_gemma":[0.010432732,0.00021821127,0.0023764342,0.00040157847,0.00040864377,0.00049933605,0.00054577243,0.00058969506,0.00015473252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24156529,0.0017773114,0.71435744,0.0003950419,0.019040098,0.00017835641,0.000451158,0.0012382644,0.0029934566,0.00023245938,0.0007423395,0.017028807],"study_design_scores_gemma":[0.009728229,0.1008251,0.8740332,0.00006479418,0.0074940077,0.00022582889,0.0002907961,0.0037732795,0.001755338,0.00025899187,0.0015036169,0.000046766265],"about_ca_topic_score_codex":0.0012960057,"about_ca_topic_score_gemma":0.001259215,"teacher_disagreement_score":0.010518362,"about_ca_system_score_codex":0.0007690155,"about_ca_system_score_gemma":0.00088678324,"threshold_uncertainty_score":0.055627048},"labels":[],"label_agreement":null},{"id":"W3096411179","doi":"10.1136/lupus-2020-000431","title":"Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis","year":2020,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Lupus Foundation of America; Foundation for the National Institutes of Health","keywords":"Medicine; Internal medicine; Titer; Gastroenterology; Hep G2; ARDS; Antibody; Immunology; Lung; Cell culture","score_opus":0.009870123267603349,"score_gpt":0.2660020529568676,"score_spread":0.25613192968926424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096411179","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7994637,0.19425729,0.00076679036,0.0001852192,0.000057824232,0.00025746328,0.003760897,0.000021087226,0.0012296815],"genre_scores_gemma":[0.9735685,0.023989154,0.0006468053,0.00014401751,0.000059606988,0.00014312097,0.0013697876,0.000008261208,0.00007067139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98997575,0.0025522397,0.0038289037,0.0016296173,0.0017346839,0.00027886033],"domain_scores_gemma":[0.95260596,0.017288914,0.022243518,0.0015171566,0.005827735,0.0005167722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006650383,0.00030867662,0.0013325975,0.005137949,0.00038897723,0.0010601645,0.0009975091,0.00058140996,0.0008709937],"category_scores_gemma":[0.022815777,0.0005098619,0.0012970485,0.0060799075,0.00075454946,0.0009384235,0.0006968885,0.00040242347,0.0002181784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003426505,0.00003705287,0.9761444,0.0061459965,0.0010250768,0.0012703461,0.0004555245,0.000048303657,0.0003479706,0.00006558292,0.00047612752,0.013640958],"study_design_scores_gemma":[0.000045103065,0.00036468892,0.97817653,0.0029152755,0.0022492425,0.010896929,0.0013795728,0.00018011245,0.00047623386,0.000035746863,0.0032445155,0.000036016274],"about_ca_topic_score_codex":0.0026962904,"about_ca_topic_score_gemma":0.0031077894,"teacher_disagreement_score":0.006650383,"about_ca_system_score_codex":0.0008690013,"about_ca_system_score_gemma":0.0012469158,"threshold_uncertainty_score":0.035171032},"labels":[],"label_agreement":null},{"id":"W3127172128","doi":"10.1136/lupus-2020-000433","title":"The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research","year":2021,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"Multiple Sclerosis Society; GlaxoSmithKline; National Institute for Health and Care Research; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Medicine; Stakeholder; Timeline; Systemic lupus erythematosus; Stakeholder engagement; Health care; Medical education; Family medicine; Public relations; Pathology; Disease","score_opus":0.16197201209890486,"score_gpt":0.44028950543382256,"score_spread":0.27831749333491773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127172128","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07833275,0.013202187,0.42487913,0.32427675,0.013947676,0.060712148,0.008368346,0.0063080587,0.069973014],"genre_scores_gemma":[0.11317292,0.0043072947,0.8162208,0.016170137,0.0010207182,0.031730387,0.007893684,0.0015780437,0.007905957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.61436635,0.29099515,0.027237903,0.014977336,0.041792903,0.0106303105],"domain_scores_gemma":[0.5009564,0.23312554,0.025777256,0.032347325,0.1401845,0.06760893],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4433869,0.0035746014,0.0036405209,0.019024193,0.010752927,0.01640007,0.012352221,0.007879655,0.01207834],"category_scores_gemma":[0.4071213,0.0026092802,0.0035540403,0.011777594,0.008512732,0.011587632,0.04345778,0.014077387,0.004856219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045074202,0.0008621144,0.011399932,0.010725469,0.00086915947,0.001209875,0.08594639,0.0027624045,0.0036934612,0.02829064,0.26348123,0.5903086],"study_design_scores_gemma":[0.0009565514,0.0013691536,0.014625386,0.025770359,0.00066492974,0.0006036258,0.1034692,0.00875317,0.0036922386,0.10556368,0.7338351,0.00069657195],"about_ca_topic_score_codex":0.01221698,"about_ca_topic_score_gemma":0.01365902,"teacher_disagreement_score":0.4433869,"about_ca_system_score_codex":0.01791993,"about_ca_system_score_gemma":0.1792917,"threshold_uncertainty_score":0.68640304},"labels":[],"label_agreement":null},{"id":"W3164908522","doi":"10.1136/lupus-2020-000448","title":"Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus","year":2021,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Women's College Hospital; University of Toronto","funders":"Lupus Foundation of America","keywords":"Medicine; Framingham Risk Score; Concordance; Internal medicine; Risk assessment; Disease; Predictive value; Risk factor","score_opus":0.0230963954617074,"score_gpt":0.30664201753371834,"score_spread":0.28354562207201095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164908522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807477,0.0009290918,0.00040023852,0.000038213777,0.0000086694,0.00003713618,0.00021629562,0.0000057781945,0.00028977357],"genre_scores_gemma":[0.9986355,0.00013063021,0.00088828045,0.0000096468,0.000011623541,0.00003842042,0.00022124991,0.000001622589,0.00006296872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600416,0.0025009073,0.00037971177,0.000241991,0.00069968216,0.0001735881],"domain_scores_gemma":[0.98984724,0.005507425,0.0031489525,0.00025850523,0.0007775514,0.00046045732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006856874,0.00060221116,0.0008057158,0.0016518208,0.00018513163,0.0008016236,0.000371318,0.0003215788,0.00081160065],"category_scores_gemma":[0.011670251,0.00019261462,0.0007202447,0.0013855485,0.0002565474,0.00043926365,0.0006263276,0.00062688626,0.0001658649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003850201,0.00003421743,0.9949333,0.000030759307,0.000094628034,0.000030890802,0.00004655293,0.000103991035,0.000068457026,0.000009373483,0.000043205295,0.004219559],"study_design_scores_gemma":[0.00008264198,0.00074056524,0.9966085,0.000032250482,0.0001410407,0.00038585658,0.000078168,0.0014292062,0.00020907394,0.00006637576,0.00021479162,0.000011458093],"about_ca_topic_score_codex":0.0005759411,"about_ca_topic_score_gemma":0.00077793404,"teacher_disagreement_score":0.006856874,"about_ca_system_score_codex":0.00022824646,"about_ca_system_score_gemma":0.00037367697,"threshold_uncertainty_score":0.03626305},"labels":[],"label_agreement":null},{"id":"W3195693614","doi":"10.1136/lupus-2021-000519","title":"Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine","year":2021,"lang":"en","type":"letter","venue":"Lupus Science & Medicine","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"Medicine; Azathioprine; Mercaptopurine; Gestation; Metabolite; Pregnancy; Obstetrics; Pharmacology; Internal medicine; Disease","score_opus":0.04352899011267845,"score_gpt":0.30492742102339115,"score_spread":0.2613984309107127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195693614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62916267,0.3424672,0.0052946853,0.0046359627,0.00026078572,0.00012614689,0.00049050193,0.00020905348,0.017352896],"genre_scores_gemma":[0.940413,0.053013407,0.0042779585,0.00075936515,0.00031183966,0.00004806371,0.00021387362,0.000020832586,0.0009415363],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9992053,0.00035095357,0.00010652624,0.000095758434,0.00019256654,0.00004888349],"domain_scores_gemma":[0.99870026,0.00063092523,0.000375532,0.00006122842,0.00013384376,0.00009828322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010278109,0.00034135702,0.0005060626,0.0008551523,0.00023434554,0.00066724734,0.00023636963,0.00045452538,0.001180914],"category_scores_gemma":[0.0035743976,0.00013501258,0.00026724956,0.00089119386,0.00020791599,0.00049456174,0.00024788125,0.0007108434,0.00024256195],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014485993,0.00025568187,0.39025053,0.0009189522,0.00020669162,0.00422912,0.0006711318,0.00056652277,0.0050451695,0.00033469437,0.002104187,0.5939688],"study_design_scores_gemma":[0.0001974713,0.0033057968,0.8904432,0.0038183876,0.00076639815,0.043709762,0.00090107805,0.0026770495,0.011617788,0.0019168281,0.040546697,0.00009951379],"about_ca_topic_score_codex":0.0011865954,"about_ca_topic_score_gemma":0.0013887872,"teacher_disagreement_score":0.0011865954,"about_ca_system_score_codex":0.0004852483,"about_ca_system_score_gemma":0.00031299217,"threshold_uncertainty_score":0.0054356456},"labels":[],"label_agreement":null},{"id":"W3199011561","doi":"10.1136/lupus-2021-000542","title":"Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review","year":2021,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cochrane Library; Quality of life (healthcare); Disease; Internal medicine; Systematic review; MEDLINE; Meta-analysis; Pediatrics","score_opus":0.02695754350713913,"score_gpt":0.3364102394239282,"score_spread":0.3094526959167891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199011561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032384817,0.995096,0.00014145322,0.000276803,0.000078839366,0.00038856606,0.00058058935,0.00000944806,0.00018974094],"genre_scores_gemma":[0.043346487,0.9536633,0.00074188283,0.000638454,0.00012500507,0.0008875861,0.00046910715,0.000007314551,0.00012099244],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99169207,0.0027274897,0.0035014665,0.0006762273,0.0011412849,0.0002615819],"domain_scores_gemma":[0.967062,0.02176584,0.007993093,0.00041236577,0.0023834638,0.00038317824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008172717,0.0016127664,0.010058639,0.010404514,0.0006508733,0.0026405088,0.0018099163,0.0020945738,0.0041781846],"category_scores_gemma":[0.040674195,0.0010209656,0.011190333,0.011360236,0.00083784526,0.0020858839,0.0014610174,0.0010596021,0.000255031],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002595278,0.000016752036,0.0025142557,0.9595226,0.023238761,0.0001128379,0.00013702225,0.000080503916,0.000084286236,0.000084410276,0.0006232288,0.013325684],"study_design_scores_gemma":[0.00043191234,0.00027200105,0.0125834355,0.70391667,0.2753234,0.0005096733,0.00027294277,0.00012901057,0.00014129638,0.00025596903,0.006103945,0.000059751903],"about_ca_topic_score_codex":0.006754843,"about_ca_topic_score_gemma":0.019034725,"teacher_disagreement_score":0.010404514,"about_ca_system_score_codex":0.0031749636,"about_ca_system_score_gemma":0.009158616,"threshold_uncertainty_score":0.04322201},"labels":[],"label_agreement":null},{"id":"W3199928535","doi":"10.1136/lupus-2021-000536","title":"Canadian workplace experiences of systemic lupus erythematosus (SLE)","year":2021,"lang":"en","type":"letter","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia, Okanagan Campus; University of British Columbia; University of Waterloo","funders":"University of Waterloo","keywords":"Systemic lupus; Medicine; Dermatology; Immunology; Internal medicine; Disease","score_opus":0.02592031891310367,"score_gpt":0.29795466844618024,"score_spread":0.2720343495330766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199928535","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95231473,0.0044434494,0.00046275315,0.0072391364,0.00024429336,0.00032641404,0.0011755412,0.000023324945,0.0337703],"genre_scores_gemma":[0.9883768,0.0025482862,0.00047007698,0.002436169,0.000024768846,0.00015672107,0.00024594253,0.000013683183,0.0057274797],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969317,0.0007840957,0.000120413664,0.0002590029,0.00092171243,0.0009830834],"domain_scores_gemma":[0.99541134,0.00090848823,0.00048064225,0.00012086451,0.0013252696,0.0017534095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029512292,0.00040679253,0.0005998988,0.0020208796,0.026965847,0.0043440005,0.0018701649,0.0011191192,0.007222711],"category_scores_gemma":[0.0046877544,0.00034178983,0.00044962994,0.0032710806,0.0056695184,0.0015649161,0.0060913377,0.0021545968,0.0004802205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006497692,0.00012080192,0.03180749,0.0006871379,0.0000100962325,0.0018376476,0.93016064,0.00005795515,0.0005524018,0.003612004,0.010065508,0.021023253],"study_design_scores_gemma":[0.000011326643,0.00005669672,0.02869873,0.0005188785,0.0000102746135,0.00045409764,0.92774343,0.000064821535,0.000085501706,0.0003805144,0.041923333,0.000052460153],"about_ca_topic_score_codex":0.9698713,"about_ca_topic_score_gemma":0.98911834,"teacher_disagreement_score":0.062384706,"about_ca_system_score_codex":0.062384706,"about_ca_system_score_gemma":0.09022493,"threshold_uncertainty_score":0.45263487},"labels":[],"label_agreement":null},{"id":"W3204004926","doi":"10.1136/lupus-2021-000511","title":"Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with lupus","year":2021,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Toronto Rehabilitation Institute; University Health Network; University of Toronto; Institute for Work & Health; Toronto Western Hospital; Western University","funders":"Department of Medicine, University of Toronto; Canadian Institutes of Health Research; Ontario Ministry of Economic Development, Job Creation and Trade; University of Toronto; Arthritis Society; Lupus Research Alliance; Ministero dello Sviluppo Economico; Lupus Foundation of America","keywords":"Medicine; Neuropsychology; Association (psychology); Cognition; Systemic lupus erythematosus; Neuropsychological testing; Clinical psychology; Psychiatry; Internal medicine; Disease; Psychotherapist; Psychology","score_opus":0.018935457814098937,"score_gpt":0.3142363543913926,"score_spread":0.29530089657729364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204004926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989104,0.00023465673,0.00013387563,0.000050485047,0.0000026865403,0.000003903279,0.00018027068,0.0000062644444,0.0004774038],"genre_scores_gemma":[0.9996412,0.000038424943,0.00010462828,0.000011515725,0.000004985594,0.0000027022268,0.0001299909,0.0000011418861,0.00006536989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900407,0.0003036685,0.00022165857,0.0001720395,0.00021116887,0.000087458524],"domain_scores_gemma":[0.99542135,0.0011195093,0.002621153,0.0002862932,0.00030247297,0.0002491784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393728,0.0004315173,0.00041347,0.0013271475,0.0003472827,0.00074484944,0.00031332386,0.00048379003,0.0011728191],"category_scores_gemma":[0.0064051775,0.0001933383,0.0005524123,0.001186583,0.00024885402,0.0005740465,0.0007050067,0.00064014795,0.0002494075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007970997,0.000019324818,0.99795544,0.0000057912725,0.000044574193,0.0000379795,0.00006814575,0.000063629166,0.00009092657,0.0000064481605,0.0000370086,0.001590969],"study_design_scores_gemma":[0.000003628576,0.00009126273,0.9989994,0.0000045173133,0.000015808679,0.00036017585,0.00009600522,0.00028241627,0.000051848063,0.00002975442,0.00006168217,0.0000034215902],"about_ca_topic_score_codex":0.002122746,"about_ca_topic_score_gemma":0.0028885892,"teacher_disagreement_score":0.002122746,"about_ca_system_score_codex":0.0003102438,"about_ca_system_score_gemma":0.00021555816,"threshold_uncertainty_score":0.00737077},"labels":[],"label_agreement":null},{"id":"W3215126343","doi":"10.1136/lupus-2021-000538","title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","year":2021,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Cilag; UCB Pharma; Chugai Pharmaceutical; Genentech; Lilly Deutschland; Medac; Servier; National Institute for Health and Care Research; Union Chimique Belge; Alexion Pharmaceuticals; Gilead Sciences; Sanofi; Biogen; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Doris (gastropod); Task force; Task (project management); Virology; Management; Public administration","score_opus":0.06174252897901825,"score_gpt":0.3772423270370254,"score_spread":0.31549979805800715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215126343","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031547681,0.41726032,0.03546895,0.3990271,0.047041498,0.038203873,0.028962849,0.0010559609,0.029824719],"genre_scores_gemma":[0.028448222,0.28804457,0.35753855,0.14298375,0.012241222,0.105184786,0.05219733,0.0008668785,0.012494783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.84695345,0.05457352,0.06279946,0.004290465,0.026017232,0.005365971],"domain_scores_gemma":[0.72919744,0.10083607,0.045532893,0.008458466,0.10746752,0.008507565],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1932142,0.0051578293,0.01131456,0.022708973,0.003980555,0.008913818,0.016346306,0.019467475,0.00677259],"category_scores_gemma":[0.235946,0.0037484036,0.026177224,0.013678814,0.004220112,0.008457391,0.011332464,0.017597027,0.006827417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001058081,0.00036657348,0.0053951717,0.18215375,0.0032074978,0.00041041579,0.0018381056,0.0021649576,0.0010510653,0.01184689,0.4532363,0.33727124],"study_design_scores_gemma":[0.0019377635,0.0004958456,0.01152954,0.4535139,0.008300035,0.0005134482,0.0015824852,0.0012694953,0.0011137337,0.011188708,0.5081209,0.00043420965],"about_ca_topic_score_codex":0.030285694,"about_ca_topic_score_gemma":0.02136338,"teacher_disagreement_score":0.1932142,"about_ca_system_score_codex":0.017417282,"about_ca_system_score_gemma":0.08484553,"threshold_uncertainty_score":0.99491054},"labels":[],"label_agreement":null},{"id":"W4200042078","doi":"10.1136/lupus-2021-000571","title":"LLDAS is an attainable treat-to-target goal in childhood-onset SLE","year":2021,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Prednisone; Hydroxychloroquine; Internal medicine; Serositis; Systemic lupus erythematosus; Pediatrics; Gastroenterology; Disease","score_opus":0.026263061838715716,"score_gpt":0.3414563992418777,"score_spread":0.31519333740316197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200042078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934245,0.0053317365,0.0010659148,0.00032497,0.000014175667,0.00003642795,0.0006698136,0.00004060744,0.0031739986],"genre_scores_gemma":[0.99849546,0.00043779457,0.0005438314,0.00003435327,0.000014678154,0.00001655481,0.00033410254,0.000003992606,0.0001192954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985008,0.0007168003,0.00016088932,0.00015064994,0.00032090905,0.00014988326],"domain_scores_gemma":[0.9956637,0.0013862285,0.002156474,0.00013163229,0.00027838055,0.000383586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017449263,0.00015590474,0.0004666178,0.00033280347,0.0001878182,0.00053400046,0.0001979755,0.00029984952,0.00092805416],"category_scores_gemma":[0.0049516405,0.00007388526,0.00019497685,0.0004347857,0.0002447508,0.00039404148,0.00034277447,0.0004969882,0.00015463533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003518216,0.00023900582,0.9385517,0.00032325587,0.0001094857,0.00016175368,0.0001898566,0.001038394,0.0021159695,0.0005038605,0.00078909966,0.0524594],"study_design_scores_gemma":[0.00012651882,0.0018725502,0.9920791,0.000096584416,0.0000777916,0.00082957605,0.00015108279,0.0011013441,0.0013536556,0.00028688114,0.0020180042,0.0000070056853],"about_ca_topic_score_codex":0.0012959142,"about_ca_topic_score_gemma":0.0014049513,"teacher_disagreement_score":0.0017449263,"about_ca_system_score_codex":0.0005886057,"about_ca_system_score_gemma":0.00057257904,"threshold_uncertainty_score":0.00922817},"labels":[],"label_agreement":null},{"id":"W4200100663","doi":"10.1136/lupus-2021-000614","title":"Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries","year":2021,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Institute of Environmental Health Sciences; University of Michigan; Centers for Disease Control and Prevention; School of Medicine, New York University; National Institutes of Health; York University; National Center for Advancing Translational Sciences; New York City Department of Health and Mental Hygiene","keywords":"Medicine; Pacific islanders; Incidence (geometry); Demography; Population; Ethnic group; Systemic lupus erythematosus; Disease; Internal medicine; Environmental health","score_opus":0.12690453615527725,"score_gpt":0.417854769488922,"score_spread":0.2909502333336447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200100663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06290202,0.9166604,0.007834699,0.0013010248,0.0006219531,0.0002862009,0.008763883,0.00025802472,0.0013717677],"genre_scores_gemma":[0.6735124,0.30580223,0.008859115,0.0014779421,0.00085669867,0.0009844638,0.007892926,0.00015371398,0.00046050534],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97555393,0.014421683,0.0037561967,0.0035418398,0.002341941,0.00038439926],"domain_scores_gemma":[0.9735291,0.017749446,0.0040550306,0.0021825302,0.00224764,0.00023632005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027416728,0.0030001781,0.009997573,0.0077989707,0.0004601219,0.00273711,0.0018444695,0.0015198056,0.0016342812],"category_scores_gemma":[0.049011603,0.0018411393,0.045559645,0.008757409,0.0005304029,0.0015877155,0.0015982859,0.002080142,0.00029028978],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018739074,0.000024717467,0.060931385,0.019758085,0.8986929,0.000105426356,0.00006140726,0.0025466895,0.00015691157,0.00021313288,0.0021178678,0.013517551],"study_design_scores_gemma":[0.0009040047,0.00017284851,0.03625892,0.004443397,0.9533949,0.000252262,0.000048902984,0.0013735314,0.00018989001,0.0005084279,0.0024163218,0.000036540296],"about_ca_topic_score_codex":0.006970417,"about_ca_topic_score_gemma":0.008849261,"teacher_disagreement_score":0.027416728,"about_ca_system_score_codex":0.001507554,"about_ca_system_score_gemma":0.0015952877,"threshold_uncertainty_score":0.14499521},"labels":[],"label_agreement":null},{"id":"W4200171911","doi":"10.1136/lupus-2021-000580","title":"Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE","year":2021,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Receiver operating characteristic; Cognition; Area under the curve; Cognitive test; Internal medicine; Cognitive impairment; Psychiatry","score_opus":0.07111569332738955,"score_gpt":0.4034289523124074,"score_spread":0.33231325898501785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200171911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989311,0.0033939618,0.0021950828,0.00019554813,0.00004138315,0.00018337247,0.0010022558,0.00008390792,0.0035934732],"genre_scores_gemma":[0.99748504,0.00027763937,0.0015974437,0.0000301793,0.000025920093,0.000073047246,0.00028173332,0.000003184347,0.00022584129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767154,0.001058452,0.00020468114,0.0001777168,0.00074726803,0.00014033052],"domain_scores_gemma":[0.9939095,0.001770665,0.002461552,0.00014858492,0.0012999095,0.00040981465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045950064,0.00072835264,0.00059176615,0.0023553316,0.00032364746,0.0007765641,0.0005666604,0.00038782108,0.0011291648],"category_scores_gemma":[0.01212126,0.00013135004,0.0008064482,0.00092012243,0.00031625657,0.0005558727,0.0005280657,0.0005231702,0.00022614072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009834232,0.00014826139,0.9693363,0.00011112973,0.00045825436,0.000076730175,0.00008955629,0.0006039504,0.0008876307,0.00006487038,0.0005887187,0.026651122],"study_design_scores_gemma":[0.000063677115,0.0011253146,0.99461186,0.0000413589,0.000112429436,0.00031543017,0.000046688765,0.0024830163,0.0006373302,0.00007560237,0.00046798447,0.000019225861],"about_ca_topic_score_codex":0.008813229,"about_ca_topic_score_gemma":0.014771653,"teacher_disagreement_score":0.008813229,"about_ca_system_score_codex":0.0006640573,"about_ca_system_score_gemma":0.0007240022,"threshold_uncertainty_score":0.024301052},"labels":[],"label_agreement":null},{"id":"W4200255638","doi":"10.1136/lupus-2021-000590","title":"Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies","year":2021,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; University of Manitoba; Toronto Western Hospital; Queen Elizabeth II Health Sciences Centre; Université Laval; Mount Sinai Hospital; Health Sciences Centre; University of Calgary; McGill University","funders":"National Institute for Health and Care Research; Lupus Foundation of America","keywords":"Medicine; Observational study; Incidence (geometry); Meta-analysis; Meta-regression; Systemic lupus erythematosus; Internal medicine; Disease","score_opus":0.1526324534583857,"score_gpt":0.4577234494748249,"score_spread":0.3050909960164392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200255638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004279758,0.99442154,0.00034333262,0.00013194096,0.00010142318,0.00012922437,0.00047998765,0.000015207479,0.000097613374],"genre_scores_gemma":[0.16373439,0.8312025,0.0019763377,0.0006903753,0.00033232907,0.0007611116,0.0010936405,0.000029903684,0.00017943751],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98430717,0.007049958,0.005064742,0.0017297546,0.0014688632,0.0003796521],"domain_scores_gemma":[0.9565125,0.030783078,0.008006171,0.0014332389,0.0028389161,0.0004260769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02066809,0.0029229524,0.017033385,0.008813679,0.0007798638,0.0034534794,0.002401211,0.0020849202,0.0027462924],"category_scores_gemma":[0.04338624,0.001554077,0.041798756,0.010784655,0.00070231827,0.001618344,0.0016734439,0.0017675657,0.0002994881],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001538395,0.000028377499,0.01114744,0.29500884,0.681997,0.00014491618,0.00007169904,0.00041411657,0.00016233356,0.000070685535,0.00038049507,0.009035741],"study_design_scores_gemma":[0.0002457086,0.00016108388,0.007191617,0.020389669,0.97050875,0.0001178898,0.000045346227,0.0001525609,0.000085090374,0.000089721085,0.0009907843,0.000021743355],"about_ca_topic_score_codex":0.006349259,"about_ca_topic_score_gemma":0.011224216,"teacher_disagreement_score":0.02066809,"about_ca_system_score_codex":0.0022931504,"about_ca_system_score_gemma":0.0040515508,"threshold_uncertainty_score":0.10930461},"labels":[],"label_agreement":null},{"id":"W4205462199","doi":"10.1136/lupus-2021-000602","title":"Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Derfner Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Duke University; Rheumatology Research Foundation","keywords":"Medicine; Hydroxychloroquine; Pregnancy; Gestation; Dosing; Internal medicine; Lupus nephritis; Pharmacokinetics; Logistic regression; Odds ratio; Obstetrics; Physiology; Coronavirus disease 2019 (COVID-19)","score_opus":0.025735433953621493,"score_gpt":0.3149324653886519,"score_spread":0.2891970314350304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205462199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814355,0.0004900371,0.00087066216,0.00011868142,0.0000024354308,0.000009448847,0.00015376323,0.000004529985,0.00020703085],"genre_scores_gemma":[0.99952734,0.00010680953,0.00023459038,0.00001223889,0.000002467828,0.00000545938,0.0000633607,0.0000013882407,0.00004621244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966647,0.002205619,0.00024844514,0.00037544593,0.00038343229,0.00012239907],"domain_scores_gemma":[0.9876101,0.007317262,0.003711293,0.0008391786,0.00030984386,0.0002123367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006675018,0.00019019611,0.00034389878,0.00021766829,0.00015626028,0.0005508292,0.0003409261,0.00041163538,0.00067581196],"category_scores_gemma":[0.018958116,0.00019855569,0.00065376074,0.00041599074,0.00034469904,0.00047569966,0.0004877672,0.0006089859,0.00007300651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035516705,0.000048034948,0.9929912,0.000026884201,0.00020564403,0.000053934466,0.00008368827,0.0011109979,0.00025627203,0.000048032656,0.000025801155,0.004794328],"study_design_scores_gemma":[0.000015510275,0.00033406753,0.99185866,0.000024515264,0.00011586128,0.00021393067,0.00006177335,0.0067450264,0.00036584097,0.00012875545,0.00013110512,0.0000049452606],"about_ca_topic_score_codex":0.0041247793,"about_ca_topic_score_gemma":0.002527958,"teacher_disagreement_score":0.006675018,"about_ca_system_score_codex":0.00048059903,"about_ca_system_score_gemma":0.0005982749,"threshold_uncertainty_score":0.035301328},"labels":[],"label_agreement":null},{"id":"W4206006306","doi":"10.1136/lupus-2021-000574","title":"Herpes zoster in SLE: prevalence, incidence and risk factors","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Western University; University of Toronto","funders":"Department of Medicine, University of Toronto; University of Toronto; Arthritis Society; Canadian Rheumatology Association","keywords":"Medicine; Incidence (geometry); Internal medicine; Disease; Proportional hazards model; Immunology","score_opus":0.016095804178952143,"score_gpt":0.2971926006124399,"score_spread":0.2810967964334878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206006306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981002,0.0013096901,0.00007994591,0.000038261063,0.0000027364492,0.0000066672405,0.00019065931,0.0000026479258,0.0002692332],"genre_scores_gemma":[0.9994948,0.0002745177,0.000057249148,0.000008745105,0.000009693971,0.0000035243293,0.00010635912,4.6171508e-7,0.000044645418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996338,0.00012663721,0.000053557633,0.00006031043,0.00007345902,0.00005234562],"domain_scores_gemma":[0.9990036,0.00018611229,0.0006093879,0.000031759027,0.000071918126,0.00009719373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000550757,0.00015688958,0.00025894362,0.0007238828,0.00019230119,0.0004418759,0.00016408577,0.00027390232,0.0013408253],"category_scores_gemma":[0.0014622324,0.000116453026,0.00020197839,0.0009078498,0.00019551467,0.00038620626,0.0002579619,0.00029837177,0.00016461153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005003958,0.000013555814,0.99879956,0.000013976295,0.00001892739,0.000034440243,0.000025108124,0.000014379302,0.0001216039,0.0000063226134,0.000017934351,0.000883975],"study_design_scores_gemma":[0.0000047693734,0.000103002116,0.9988605,0.000011229465,0.000014890689,0.000642573,0.00013228256,0.00007657906,0.00003754667,0.000013408351,0.00010130063,0.0000019123827],"about_ca_topic_score_codex":0.0010827865,"about_ca_topic_score_gemma":0.0009018716,"teacher_disagreement_score":0.0013408253,"about_ca_system_score_codex":0.00012485727,"about_ca_system_score_gemma":0.00020307928,"threshold_uncertainty_score":0.0044855475},"labels":[],"label_agreement":null},{"id":"W4220659684","doi":"10.1136/lupus-2021-000634","title":"Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria","year":2022,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"National Institute for Health and Care Research; Alexion Pharmaceuticals; Biogen; Gilead Sciences; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Manchester Biomedical Research Centre; Eli Lilly and Company","keywords":"Medicine; Disease; Systemic lupus erythematosus; Intensive care medicine; Effect modification; Internal medicine","score_opus":0.11886182132972262,"score_gpt":0.42204588231507434,"score_spread":0.3031840609853517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220659684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009605781,0.66335547,0.120631516,0.1866415,0.015148228,0.0018158283,0.00053448597,0.0001595659,0.010752898],"genre_scores_gemma":[0.046740264,0.39355686,0.41756997,0.108183354,0.015728587,0.011990952,0.0016764897,0.00022693345,0.004326599],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9225986,0.043367505,0.015357845,0.003993592,0.013323303,0.0013591843],"domain_scores_gemma":[0.88816166,0.0844606,0.0061699064,0.0032414359,0.015936386,0.0020299472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14464188,0.0036266341,0.008130332,0.013730874,0.003781313,0.014070963,0.012796806,0.009305401,0.0029364899],"category_scores_gemma":[0.0966338,0.0018038282,0.006428255,0.009583063,0.027154945,0.019263366,0.009381763,0.024461418,0.001227152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105794825,0.00008956507,0.00062636397,0.02102429,0.00026737273,0.00036625072,0.0032518029,0.0011666673,0.00034167277,0.81261057,0.037089754,0.123059854],"study_design_scores_gemma":[0.00016112249,0.00019441682,0.0010452693,0.03789961,0.00031438045,0.0009775365,0.0018280011,0.001863522,0.00021571227,0.49448642,0.46081552,0.00019843143],"about_ca_topic_score_codex":0.0077756196,"about_ca_topic_score_gemma":0.007952073,"teacher_disagreement_score":0.14464188,"about_ca_system_score_codex":0.016382873,"about_ca_system_score_gemma":0.03062603,"threshold_uncertainty_score":0.7649485},"labels":[],"label_agreement":null},{"id":"W4220721988","doi":"10.1136/lupus-2021-000651","title":"Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data","year":2022,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Agency for Healthcare Research and Quality","keywords":"Medicine; Hydroxychloroquine; Systemic lupus erythematosus; Meta-analysis; Obstetrics; Pregnancy; Family medicine; Immunology; Pediatrics; Intensive care medicine; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.39542734059082185,"score_gpt":0.44146908536766094,"score_spread":0.04604174477683909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220721988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056359887,0.9340958,0.0044125365,0.000705821,0.0004981594,0.00042809657,0.0025951718,0.00013057826,0.0007739823],"genre_scores_gemma":[0.8449252,0.1436963,0.0060263895,0.0011080458,0.00033302806,0.0010755528,0.0021824325,0.00010175251,0.00055124256],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9771757,0.015753783,0.0029542681,0.002279203,0.0013401246,0.0004969383],"domain_scores_gemma":[0.95226574,0.03778417,0.0046965224,0.0029678093,0.0018546369,0.000431077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02698805,0.002415296,0.011266913,0.004025922,0.0006132468,0.0030469901,0.0018959127,0.0021910458,0.0027316876],"category_scores_gemma":[0.056219693,0.0014660095,0.06258682,0.0045318725,0.00056700135,0.0014515097,0.0015222251,0.0023052064,0.00025187797],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004309342,0.000026101307,0.01230405,0.024256073,0.9536162,0.00007344579,0.000039115388,0.0008072356,0.00015391571,0.00007617491,0.00033023636,0.0040080943],"study_design_scores_gemma":[0.00071016775,0.00028733525,0.007428759,0.0023441014,0.9876494,0.00006571975,0.00002370349,0.00046595506,0.000084147476,0.00021754584,0.0007051288,0.000017950237],"about_ca_topic_score_codex":0.0064926166,"about_ca_topic_score_gemma":0.008772186,"teacher_disagreement_score":0.02698805,"about_ca_system_score_codex":0.0014751133,"about_ca_system_score_gemma":0.0018252503,"threshold_uncertainty_score":0.14272815},"labels":[],"label_agreement":null},{"id":"W4220865624","doi":"10.1136/lupus-2022-000659","title":"“There’s so much to be done”: a qualitative study to elucidate research priorities in childhood-onset systemic lupus erythematosus","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Childhood Arthritis and Rheumatology Research Alliance; Lupus Research Alliance; Lupus Foundation of America","keywords":"Medicine; Qualitative research; Systemic lupus; Systemic lupus erythematosus; Immunology; Intensive care medicine; Disease; Pathology","score_opus":0.0776643922198947,"score_gpt":0.4254782165625891,"score_spread":0.3478138243426944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220865624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96621543,0.0024151052,0.008329106,0.012508961,0.0002506793,0.0013981815,0.00039863813,0.000040500938,0.008443424],"genre_scores_gemma":[0.9848171,0.0024047936,0.0047468874,0.003262325,0.00004206215,0.0013529352,0.00013337209,0.000039779727,0.0032007576],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9627159,0.031124275,0.0008810507,0.0011342634,0.0014611537,0.002683273],"domain_scores_gemma":[0.9358354,0.05145842,0.0030491352,0.0009943614,0.004255434,0.0044071577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041482653,0.0007712176,0.0012247651,0.0023167788,0.013791408,0.0054881866,0.0024320914,0.0028355713,0.0028421786],"category_scores_gemma":[0.04616863,0.00082059536,0.00070219586,0.002464424,0.013263799,0.0060772174,0.0065795504,0.004220591,0.00043166958],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002367,0.000025367093,0.0011937252,0.00023601532,0.0000031391746,0.0006837349,0.99377126,0.0000353009,0.00036745836,0.0009897074,0.0005137846,0.0021568967],"study_design_scores_gemma":[0.0000036201275,0.000023425617,0.00036639007,0.00026437748,0.0000024187016,0.00017988172,0.9944517,0.000053558604,0.00012291237,0.00033184217,0.004192275,0.000007527816],"about_ca_topic_score_codex":0.009076014,"about_ca_topic_score_gemma":0.0133923385,"teacher_disagreement_score":0.041482653,"about_ca_system_score_codex":0.01019832,"about_ca_system_score_gemma":0.0137638785,"threshold_uncertainty_score":0.2193839},"labels":[],"label_agreement":null},{"id":"W4221126414","doi":"10.1136/lupus-2021-000605","title":"Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Université Laval","keywords":"Medicine; Platelet; Platelet activation; GPVI; Neutrophil extracellular traps; Inflammation; Phosphatidylserine; Immunology; Internal medicine; Thrombosis; Flow cytometry; Systemic lupus erythematosus; Disease; Systemic inflammation; Gastroenterology","score_opus":0.01077643122971964,"score_gpt":0.23756276937153975,"score_spread":0.22678633814182012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221126414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981712,0.0009462208,0.00013959293,0.00004121891,0.000008075156,0.0000058877067,0.00011058423,0.000006948352,0.0005703169],"genre_scores_gemma":[0.99958366,0.00015351133,0.000061072955,0.000009750505,0.000012465757,0.000002513976,0.00007310243,0.0000010439172,0.00010283633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964046,0.00009398393,0.000053324515,0.000093313836,0.00006896731,0.00004992025],"domain_scores_gemma":[0.9985006,0.00030546504,0.00081936276,0.00008297507,0.000104433384,0.00018720419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039394025,0.00030527762,0.00041103875,0.0008760881,0.000384413,0.0006133684,0.00025143477,0.0005076777,0.0026750597],"category_scores_gemma":[0.0019434902,0.00023325902,0.00033298912,0.00080773555,0.00024613988,0.000370148,0.00029796016,0.00060970924,0.0002716522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002065597,0.00002670114,0.9970626,0.00002056507,0.000051586467,0.0005327727,0.000062464525,0.00003700248,0.0005549652,0.000026737398,0.000055738066,0.0013621775],"study_design_scores_gemma":[0.000008888967,0.00016608133,0.9940076,0.000012586748,0.00007316027,0.0049407724,0.00009787722,0.00023136195,0.00017765784,0.000059290338,0.00021970225,0.0000050052495],"about_ca_topic_score_codex":0.000604013,"about_ca_topic_score_gemma":0.00050684024,"teacher_disagreement_score":0.0026750597,"about_ca_system_score_codex":0.00012602446,"about_ca_system_score_gemma":0.00011519978,"threshold_uncertainty_score":0.008948982},"labels":[],"label_agreement":null},{"id":"W4223481026","doi":"10.1136/lupus-2022-000667","title":"Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Alberta Bone and Joint Health Institute; University of Calgary","funders":"Arthritis Society; University of Calgary","keywords":"Autoantibody; Medicine; Immunology; Cytokine; Cohort; Antibody; Internal medicine","score_opus":0.02422703593901829,"score_gpt":0.29743914331677557,"score_spread":0.27321210737775725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223481026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996412,0.000056769215,0.00003392471,0.00000910111,0.0000019754948,0.000006169634,0.0000727994,0.0000013867922,0.00017658979],"genre_scores_gemma":[0.99960417,0.000049118753,0.000036961763,0.000024993315,0.000009442275,0.000007811417,0.00015505546,0.0000021121673,0.00011042491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996816,0.00006459465,0.000044534725,0.00008881519,0.00006293678,0.000057485104],"domain_scores_gemma":[0.99930274,0.00012075175,0.00017647026,0.000060620936,0.000098084565,0.00024142831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029707348,0.00033646345,0.0003737217,0.0012518145,0.0006292873,0.00056072546,0.00024264245,0.0003624869,0.001682897],"category_scores_gemma":[0.0012914274,0.0002542611,0.0003036715,0.00060007296,0.0003070555,0.00026087972,0.00038991915,0.0004243477,0.00041762678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024109051,0.000092913586,0.9927418,0.00001218532,0.000027167547,0.0010775363,0.00041610093,0.000019090947,0.00382945,0.000016882974,0.00008816677,0.0014376526],"study_design_scores_gemma":[0.000015020186,0.00035679963,0.9953055,0.0000056731956,0.000024401754,0.0030552894,0.0005379395,0.000069939706,0.00036305597,0.00001305061,0.00024806446,0.0000051842767],"about_ca_topic_score_codex":0.0025458217,"about_ca_topic_score_gemma":0.0020634513,"teacher_disagreement_score":0.0025458217,"about_ca_system_score_codex":0.00019880422,"about_ca_system_score_gemma":0.0001710053,"threshold_uncertainty_score":0.005629897},"labels":[],"label_agreement":null},{"id":"W4281746658","doi":"10.1136/lupus-2021-000584","title":"Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"Medical Research Council; Manchester Biomedical Research Centre; University of Birmingham; University of Manchester; University of Bath; University of Leeds; National Institute for Health and Care Research; Sanofi; Genentech; Sandwell and West Birmingham Hospitals NHS Trust; University College London; Imperial College London; Eli Lilly and Company; AstraZeneca; King's College London","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Internal medicine; Cohort; Receiver operating characteristic; Logistic regression; Population; Gastroenterology; Disease","score_opus":0.0474695270629796,"score_gpt":0.35752416659115666,"score_spread":0.3100546395281771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281746658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95871186,0.0265884,0.0018007492,0.00907912,0.00021217638,0.000053886048,0.001350725,0.000036143756,0.0021669096],"genre_scores_gemma":[0.9931166,0.0025660242,0.0012064973,0.0009850399,0.00061997544,0.0000602189,0.0012145819,0.000021114945,0.00020993379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906123,0.007808357,0.00046419405,0.00049091567,0.0004678584,0.00015633118],"domain_scores_gemma":[0.9744805,0.016251814,0.005422758,0.001720206,0.00090985396,0.001214789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019197593,0.00048181892,0.001695817,0.0003087764,0.00023791617,0.0014645772,0.0005188529,0.00065028365,0.0011990017],"category_scores_gemma":[0.024487114,0.00020033793,0.001003554,0.00071188883,0.00045007758,0.001076713,0.0005656397,0.0022174772,0.00019465605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026861537,0.0003575528,0.8626801,0.00085063674,0.0064818645,0.00029428018,0.00039568337,0.004338783,0.00063874247,0.0011197639,0.011787671,0.08419329],"study_design_scores_gemma":[0.007838727,0.007348656,0.9362825,0.0012359605,0.005908281,0.0009010285,0.0005940171,0.022066541,0.0006488851,0.006266907,0.010769224,0.00013918089],"about_ca_topic_score_codex":0.00049346127,"about_ca_topic_score_gemma":0.00073652324,"teacher_disagreement_score":0.019197593,"about_ca_system_score_codex":0.00029898915,"about_ca_system_score_gemma":0.00051474094,"threshold_uncertainty_score":0.10152781},"labels":[],"label_agreement":null},{"id":"W4282934809","doi":"10.1136/lupus-2022-000668","title":"Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosus","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Mitacs; Canadian Institutes of Health Research; Research Nova Scotia; Nova Scotia Health Research Foundation; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada","keywords":"Medicine; Autoantibody; Serology; Internal medicine; Neuropsychology; Cognition; Immunology; Antibody; Psychiatry","score_opus":0.016058422066741726,"score_gpt":0.30454188345475375,"score_spread":0.288483461388012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282934809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986966,0.0008962111,0.00009241366,0.000047935944,0.0000038504777,0.0000033667773,0.000038430215,0.0000055007454,0.00021571842],"genre_scores_gemma":[0.9997031,0.00014403454,0.000056631758,0.000014209991,0.000010228027,0.0000016244414,0.000030234758,7.122492e-7,0.00003923759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939156,0.0002427096,0.0000949715,0.00007749612,0.00012616886,0.000067106455],"domain_scores_gemma":[0.9963193,0.0010074772,0.0020508294,0.00012474993,0.00020737346,0.0002902659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014592543,0.00059233274,0.0005424052,0.00090733217,0.00026624883,0.0006872919,0.000300384,0.00048442686,0.00138264],"category_scores_gemma":[0.0041969256,0.00029757264,0.000603353,0.00082586997,0.0003931151,0.0005974723,0.0005059726,0.0006813905,0.00022693645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000539353,0.00009524532,0.995141,0.000034333374,0.00017840063,0.00026191978,0.00005629145,0.00013200256,0.0005533878,0.000011893108,0.00003640874,0.00295973],"study_design_scores_gemma":[0.000020174173,0.00024009655,0.99796164,0.000017763385,0.000067191344,0.0009694156,0.000040843373,0.0004717859,0.000107796535,0.00004185292,0.000057277834,0.0000043230116],"about_ca_topic_score_codex":0.0012605902,"about_ca_topic_score_gemma":0.0012432265,"teacher_disagreement_score":0.0014592543,"about_ca_system_score_codex":0.00024208346,"about_ca_system_score_gemma":0.00026453554,"threshold_uncertainty_score":0.007717371},"labels":[],"label_agreement":null},{"id":"W4293239262","doi":"10.1136/lupus-2022-000712","title":"Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Janssen Biotech","keywords":"Medicine; Content validity; Internal medicine; Clinical psychology; Psychometrics","score_opus":0.17590226776615075,"score_gpt":0.31990953264174926,"score_spread":0.1440072648755985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293239262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64285326,0.303705,0.0113845905,0.016945746,0.0013692683,0.0018930649,0.0025530302,0.000052523512,0.019243423],"genre_scores_gemma":[0.96288943,0.024591083,0.0067452425,0.002995092,0.0003024627,0.0011544786,0.0010751424,0.000022584392,0.00022439039],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9230014,0.046363883,0.010794406,0.0044205533,0.014598841,0.0008208509],"domain_scores_gemma":[0.40965593,0.5246859,0.028863957,0.00916072,0.026785698,0.00084779994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.112237565,0.0005655414,0.0013833961,0.005643043,0.0009325338,0.0047143404,0.0017510292,0.0021206005,0.003129574],"category_scores_gemma":[0.34464592,0.0004861773,0.0021570167,0.004469025,0.00560216,0.0029754145,0.003013204,0.0016437859,0.00036086174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029396785,0.00081364124,0.37575743,0.08281045,0.007875211,0.0005310548,0.035384312,0.0008268511,0.002735768,0.0072744247,0.0029037846,0.48014733],"study_design_scores_gemma":[0.0011163944,0.0034698679,0.7352029,0.15044273,0.008758721,0.0020804359,0.05064662,0.003064569,0.002592145,0.010429964,0.031977408,0.00021824987],"about_ca_topic_score_codex":0.0026412683,"about_ca_topic_score_gemma":0.0035200885,"teacher_disagreement_score":0.112237565,"about_ca_system_score_codex":0.0036382347,"about_ca_system_score_gemma":0.00669888,"threshold_uncertainty_score":0.5935761},"labels":[],"label_agreement":null},{"id":"W4307497502","doi":"10.1136/lupus-2022-000755","title":"Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Systems, Applications & Products in Data Processing (Canada); Centre hospitalier de l'Université Laval; University of Manitoba; University of Calgary; McGill University; University of Waterloo; McGill University Health Centre; Dalhousie University; University of Toronto","funders":"Canadian Institutes of Health Research; Feinberg School of Medicine; EMD Serono; National Institutes of Health; National Center for Advancing Translational Sciences; National Research Foundation of Korea; Eli Lilly and Company; Eusko Jaurlaritza; National Research Foundation; National Institute for Health and Care Research; Arthritis Society; Glenmark Pharmaceuticals; Manchester Biomedical Research Centre; Mallinckrodt Pharmaceuticals; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Lupus Research Alliance; McGill University; Astellas Pharma; University of Calgary; Biogen; Pfizer; Northwestern University; National Center for Research Resources; Versus Arthritis; GlaxoSmithKline; Johns Hopkins University; Bristol-Myers Squibb; AstraZeneca; Université Laval","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Hydroxychloroquine; Intensive care medicine; Immunology; Virology; Disease; Internal medicine; Infectious disease (medical specialty); Outbreak","score_opus":0.021815704601478123,"score_gpt":0.3025545220550512,"score_spread":0.28073881745357304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307497502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984665,0.00017777532,0.000018961542,0.00021041273,0.0000062291883,0.000012692815,0.000490019,0.0000019240488,0.0006156393],"genre_scores_gemma":[0.99911696,0.00017033209,0.00005549341,0.00015793623,0.000013631785,0.000017969674,0.00027197713,9.761947e-7,0.00019481366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999025,0.0003865296,0.00015059052,0.000103321145,0.00014276699,0.00019186205],"domain_scores_gemma":[0.9938446,0.0011830383,0.003738037,0.0001354905,0.0003055289,0.0007932801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011258953,0.00017119225,0.00026225785,0.000801202,0.0006160834,0.0010788409,0.0002126952,0.0006273555,0.0019975929],"category_scores_gemma":[0.005937308,0.00022340487,0.00041126704,0.0009514508,0.0003024559,0.001095382,0.0007536702,0.0008816503,0.00033685134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010910731,0.000082899096,0.995634,0.000025819149,0.000024885172,0.00007823373,0.001051321,0.000025080253,0.00010453205,0.0000067776805,0.00018940518,0.0026678527],"study_design_scores_gemma":[0.00001037906,0.00031739075,0.99561054,0.00003160688,0.000021229771,0.00027407854,0.0031366537,0.000067318644,0.00006220592,0.000009326969,0.0004503179,0.000009072378],"about_ca_topic_score_codex":0.008802277,"about_ca_topic_score_gemma":0.011398109,"teacher_disagreement_score":0.008802277,"about_ca_system_score_codex":0.000424065,"about_ca_system_score_gemma":0.00054756436,"threshold_uncertainty_score":0.01750207},"labels":[],"label_agreement":null},{"id":"W4309617441","doi":"10.1136/lupus-2022-000789","title":"Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine","year":2022,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Université Laval; University of Calgary; Dalhousie University; University of Toronto; University of Manitoba; Toronto Western Hospital; Centre for Advancing Health Outcomes; McGill University Health Centre","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; National Center for Chronic Disease Prevention and Health Promotion; Versus Arthritis; Arthritis Research UK; Canadian Institutes of Health Research; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Hydroxychloroquine; Toxicity; Internal medicine; Retinal; Cohort; Systemic lupus erythematosus; Univariate analysis; Cumulative dose; Body mass index; Cumulative incidence; Ophthalmology; Disease; Multivariate analysis; Coronavirus disease 2019 (COVID-19)","score_opus":0.009993593920788496,"score_gpt":0.2610572343716376,"score_spread":0.25106364045084906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309617441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994425,0.00009117017,0.000037623515,0.000021250233,0.0000026388282,0.00000641276,0.00026219987,0.0000020816203,0.00013405531],"genre_scores_gemma":[0.9991842,0.00008700613,0.00007332466,0.000035112844,0.00001234997,0.000008754184,0.00046832577,0.0000025377822,0.0001283499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994955,0.00012439465,0.000039891205,0.00015456573,0.00010169463,0.00008383557],"domain_scores_gemma":[0.99736977,0.00032117253,0.0013701799,0.00032562786,0.00023379485,0.00037950458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011729214,0.0003810737,0.00040942404,0.00062967633,0.00058041967,0.000880905,0.0005141736,0.00035469275,0.0014259735],"category_scores_gemma":[0.0027487173,0.00040394068,0.0005367422,0.0009453803,0.0002549923,0.00051785115,0.00059624924,0.0007612355,0.00021797797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056280165,0.000012575875,0.99951124,0.000001388699,0.00001797927,0.000032925156,0.000021951299,0.000010739977,0.00006361767,0.0000027771528,0.000027677654,0.00024087193],"study_design_scores_gemma":[0.000011488691,0.00008257914,0.9993032,0.0000042510187,0.000023734192,0.00027576936,0.000059408663,0.00012784815,0.00002598037,0.0000054339685,0.00007798828,0.0000021798407],"about_ca_topic_score_codex":0.012433945,"about_ca_topic_score_gemma":0.011889747,"teacher_disagreement_score":0.012433945,"about_ca_system_score_codex":0.0004697138,"about_ca_system_score_gemma":0.00047477306,"threshold_uncertainty_score":0.024723172},"labels":[],"label_agreement":null},{"id":"W4320730827","doi":"10.1136/lupus-2023-000901","title":"Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective","year":2023,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"EMD Serono; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Systemic lupus erythematosus; Clinical trial; Drug development; Stakeholder engagement; Alternative medicine; Stakeholder; Disease; Intensive care medicine; Family medicine; Drug; Public relations; Pathology; Psychiatry","score_opus":0.2211303558865454,"score_gpt":0.4409332257526152,"score_spread":0.21980286986606978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320730827","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026442744,0.0025370019,0.0030199224,0.9284146,0.053575832,0.00075249816,0.0007047085,0.00011220238,0.008238929],"genre_scores_gemma":[0.073526084,0.011616088,0.01852119,0.61015016,0.18357995,0.005179842,0.0024714768,0.0008803316,0.094074935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9685014,0.01924432,0.0016894611,0.0014554053,0.006812727,0.0022966636],"domain_scores_gemma":[0.89711297,0.025774086,0.004614949,0.0025943313,0.03217165,0.037731986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10043854,0.0015640053,0.00096026866,0.0011740475,0.0045912913,0.008761259,0.002545053,0.015136264,0.017310588],"category_scores_gemma":[0.078876086,0.0008188612,0.0017035316,0.0008259455,0.0017525177,0.0053999117,0.008993768,0.020686246,0.006585537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015686636,0.000116073854,0.000730302,0.00023091242,0.00003136675,0.00033544062,0.0008411663,0.00009275314,0.0006559978,0.0013722754,0.9759721,0.019464757],"study_design_scores_gemma":[0.00015294114,0.00022033627,0.002647343,0.00065180403,0.000038020604,0.0004514161,0.0025249238,0.00035616793,0.0004379495,0.0030251518,0.98942214,0.00007183262],"about_ca_topic_score_codex":0.0025604495,"about_ca_topic_score_gemma":0.004549967,"teacher_disagreement_score":0.10043854,"about_ca_system_score_codex":0.0043675317,"about_ca_system_score_gemma":0.022340633,"threshold_uncertainty_score":0.5311761},"labels":[],"label_agreement":null},{"id":"W4362521472","doi":"10.1136/lupus-2022-000799","title":"Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study","year":2023,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Phenotype; Immune system; Disease; Systemic lupus erythematosus; Immunology; Transcriptome; Clinical phenotype; Gene; Internal medicine; Biology; Genetics; Gene expression","score_opus":0.06373381213541594,"score_gpt":0.350998446570038,"score_spread":0.287264634434622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362521472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896634,0.00013967122,0.0006096805,0.000015463875,9.900943e-7,0.000017578634,0.00015518455,0.0000042829565,0.000090886235],"genre_scores_gemma":[0.9974892,0.00015298412,0.0016341261,0.000036808426,0.0000056518875,0.000029858902,0.00045687173,0.0000060795596,0.0001883507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995053,0.0001556481,0.000021577793,0.00014913105,0.00008093289,0.00008748763],"domain_scores_gemma":[0.99956685,0.000113482194,0.00013465258,0.000065818975,0.00005278238,0.0000664249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008050369,0.0005386945,0.00039402742,0.00060122303,0.00040896802,0.00049282995,0.00019389177,0.00030218068,0.00067378685],"category_scores_gemma":[0.0005090692,0.00014000913,0.0005587587,0.0005869567,0.00060239603,0.00019448332,0.00054497295,0.00037027997,0.00018860439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003517738,0.0005937854,0.5600021,0.00017694845,0.00039732797,0.0012025312,0.0017774055,0.00049314846,0.4181296,0.00010556586,0.0001738997,0.013430079],"study_design_scores_gemma":[0.00004473096,0.0013646357,0.9767785,0.000011774899,0.00013495928,0.0020097035,0.000802947,0.00053792587,0.01750974,0.00006135919,0.0007276169,0.000016045751],"about_ca_topic_score_codex":0.0012203894,"about_ca_topic_score_gemma":0.0014324071,"teacher_disagreement_score":0.0012203894,"about_ca_system_score_codex":0.00040416582,"about_ca_system_score_gemma":0.0003271489,"threshold_uncertainty_score":0.0042575},"labels":[],"label_agreement":null},{"id":"W4383872196","doi":"10.1136/lupus-2023-000923","title":"Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE","year":2023,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Toronto Rehabilitation Institute; University of Toronto; McMaster University; University Health Network","funders":"Department of Medicine, University of Toronto; Canadian Institutes of Health Research; Arthritis Society; National Institute on Aging; Physicians' Services Incorporated Foundation; Lupus Research Alliance; University of Toronto; University Health Network; Pfizer","keywords":"Medicine; Angiotensin receptor; Pharmacology; Cognition; Cognitive impairment; ACE inhibitor; Angiotensin Receptor Blockers; Renin–angiotensin system; Receptor; Internal medicine; Angiotensin II; Angiotensin-converting enzyme; Psychiatry; Blood pressure","score_opus":0.02441003678953367,"score_gpt":0.24497060336324616,"score_spread":0.22056056657371248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383872196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913114,0.00041797062,0.00003177505,0.00002780364,0.0000027262447,0.0000051838556,0.00014878406,0.000002553417,0.00023207549],"genre_scores_gemma":[0.9995957,0.00011702326,0.00004532236,0.00001489557,0.000009367911,0.00000513138,0.00009743859,6.5144553e-7,0.00011439257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995888,0.000121819125,0.000063584266,0.000073230214,0.00009433619,0.000058139965],"domain_scores_gemma":[0.9984042,0.00038205762,0.00087978283,0.0000647104,0.00007592937,0.00019330328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006041344,0.0002628992,0.00053078745,0.0005490661,0.0004330433,0.00052124314,0.00021813951,0.00035477642,0.001980775],"category_scores_gemma":[0.001947857,0.00020988609,0.00042092818,0.0009058081,0.00017296973,0.00031880944,0.00029584116,0.0005835604,0.0002348058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046681962,0.00006232536,0.997957,0.000014939808,0.000048227485,0.00008636283,0.00004211317,0.00002594997,0.00017091804,0.0000043994805,0.000035485475,0.0010855373],"study_design_scores_gemma":[0.000020747215,0.00038247247,0.9987684,0.000007643604,0.000036237623,0.0004434011,0.00008041738,0.00012381919,0.00004230382,0.000009819263,0.00008189593,0.0000028903428],"about_ca_topic_score_codex":0.0016089067,"about_ca_topic_score_gemma":0.0027636413,"teacher_disagreement_score":0.001980775,"about_ca_system_score_codex":0.00020220384,"about_ca_system_score_gemma":0.0002421684,"threshold_uncertainty_score":0.0066263676},"labels":[],"label_agreement":null},{"id":"W4385237581","doi":"10.1136/lupus-2022-000890","title":"Improving resource utilisation in SLE drug development through innovative trial design","year":2023,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Genentech; National Institutes of Health; Idorsia Pharmaceuticals; Acceleron; Lupus Research Alliance; Alexion Pharmaceuticals; Celgene; Biogen; Mallinckrodt Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Drug development; Drug; Resource (disambiguation); Intensive care medicine; Pharmacology","score_opus":0.205565501183303,"score_gpt":0.42645936464597767,"score_spread":0.22089386346267467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385237581","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07221965,0.049327716,0.5861686,0.026910413,0.006317668,0.22140464,0.002086543,0.0014298423,0.034135006],"genre_scores_gemma":[0.26656333,0.008903779,0.48358396,0.007929429,0.0013037784,0.22885792,0.0007145379,0.00024950958,0.0018937371],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.47052875,0.49955586,0.014032134,0.0044220556,0.009443832,0.002017338],"domain_scores_gemma":[0.6597421,0.27297786,0.02534794,0.02503985,0.011171323,0.0057208682],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3356643,0.0017848553,0.0035725352,0.0024082966,0.00088486006,0.005682934,0.0030829404,0.0036231813,0.010350441],"category_scores_gemma":[0.32963148,0.0015429776,0.004256357,0.0024255512,0.0031057352,0.004478059,0.0053663286,0.0050407653,0.0020583135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049544573,0.0033083637,0.01076927,0.016174605,0.008000418,0.00054089766,0.0019222061,0.05204097,0.0023737594,0.073174104,0.014436331,0.7677146],"study_design_scores_gemma":[0.1901285,0.08508826,0.021340257,0.026000783,0.009990875,0.0014112636,0.0016083649,0.10074323,0.007380506,0.34102157,0.21438394,0.0009024889],"about_ca_topic_score_codex":0.0007628989,"about_ca_topic_score_gemma":0.00093988166,"teacher_disagreement_score":0.6643357,"about_ca_system_score_codex":0.0038933835,"about_ca_system_score_gemma":0.017106054,"threshold_uncertainty_score":0.8192442},"labels":[],"label_agreement":null},{"id":"W4389505125","doi":"10.1136/lupus-2023-000982","title":"Canadian patient experiences of lupus nephritis: a qualitative analysis","year":2023,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Waterloo","funders":"Arthritis Society; University of Calgary; Alexion Pharmaceuticals; Sanofi; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Lupus nephritis; Context (archaeology); Health care; Systemic lupus erythematosus; Family medicine; Mental health; Disease; Internal medicine; Psychiatry","score_opus":0.03810571683081389,"score_gpt":0.3816260169920734,"score_spread":0.3435203001612595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389505125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98434895,0.0016251246,0.00051749963,0.0035043987,0.00007481691,0.00034856136,0.00076377764,0.000018316638,0.00879858],"genre_scores_gemma":[0.99469006,0.0014699007,0.0005339097,0.0008833723,0.000017859746,0.0002328074,0.0002434787,0.000022095988,0.0019064571],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9919008,0.003688371,0.00031707293,0.0005030172,0.0013655613,0.002225083],"domain_scores_gemma":[0.98465466,0.008273672,0.0012539388,0.00028818537,0.0029170176,0.002612488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009469933,0.0007077347,0.00093661156,0.0028595848,0.01700296,0.005463276,0.002875436,0.0016719264,0.003990159],"category_scores_gemma":[0.017364496,0.0007179733,0.00063371705,0.0051925494,0.009206129,0.0026188393,0.006709852,0.0032830874,0.00026716728],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028009334,0.0000143455645,0.0037608815,0.00013771497,0.00000369459,0.0003901772,0.992242,0.000020246162,0.00014592842,0.0004025361,0.0006084624,0.002246089],"study_design_scores_gemma":[0.0000029218234,0.000011424781,0.0032850183,0.00015348477,0.0000030753254,0.000096599746,0.99265784,0.000030330872,0.000033978395,0.000054068565,0.0036604065,0.000010849195],"about_ca_topic_score_codex":0.72700095,"about_ca_topic_score_gemma":0.8084845,"teacher_disagreement_score":0.27299905,"about_ca_system_score_codex":0.052216545,"about_ca_system_score_gemma":0.052111994,"threshold_uncertainty_score":0.5492135},"labels":[],"label_agreement":null},{"id":"W4390023689","doi":"10.1136/lupus-2023-001032","title":"Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature","year":2023,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"AstraZeneca","keywords":"Medicine; Internal medicine; Rheumatology; Systemic lupus erythematosus; Observational study; Cohort; Demographics; Prospective cohort study; Population; Disease; Demography","score_opus":0.08835196761126496,"score_gpt":0.41475462251708534,"score_spread":0.3264026549058204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390023689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520875,0.00045617882,0.00017649545,0.00011969462,0.0000106399875,0.00004759185,0.013388643,0.000008136347,0.0005838554],"genre_scores_gemma":[0.98645175,0.00024940842,0.00022287216,0.00008783317,0.00002189631,0.000100501005,0.012685794,0.0000058260753,0.00017418656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982425,0.00048583656,0.0003084177,0.00042262214,0.0003575266,0.00018307664],"domain_scores_gemma":[0.9949941,0.0004988467,0.0026926398,0.00044070237,0.0007344364,0.00063925027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021547598,0.00030465427,0.00055995904,0.0010085069,0.00047886543,0.0008175755,0.000551646,0.0005008371,0.0016787156],"category_scores_gemma":[0.0046932907,0.00036528884,0.0005127765,0.002523871,0.00022896663,0.00058363634,0.0009881078,0.00089514727,0.00045952667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014542631,0.00001874016,0.9986488,0.000015363325,0.00007826845,0.000017426652,0.000045018114,0.000026701973,0.00005299586,0.000012169802,0.00041988678,0.00051923125],"study_design_scores_gemma":[0.00004650781,0.000071239134,0.9990305,0.000019016452,0.000040308383,0.000116804375,0.000107514345,0.000110322384,0.00001626945,0.0000149473935,0.00042248427,0.0000041306066],"about_ca_topic_score_codex":0.012637093,"about_ca_topic_score_gemma":0.017189488,"teacher_disagreement_score":0.012637093,"about_ca_system_score_codex":0.000490692,"about_ca_system_score_gemma":0.0008770399,"threshold_uncertainty_score":0.025127053},"labels":[],"label_agreement":null},{"id":"W4390631738","doi":"10.1136/lupus-2023-001038","title":"Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Lupus Foundation of America","keywords":"Neutrophil extracellular traps; Lupus nephritis; Medicine; Cohort; Neutrophil elastase; Internal medicine; Systemic lupus erythematosus; Biomarker; Elastase; Immunology; Gastroenterology; HMGB1; Inflammation; Biology; Enzyme; Disease; Genetics","score_opus":0.023585234427546772,"score_gpt":0.2902973806694813,"score_spread":0.2667121462419345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390631738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950266,0.00022563673,0.000090722635,0.000012067913,0.0000025374388,0.000004438436,0.00006850141,0.0000026208909,0.00009096885],"genre_scores_gemma":[0.99972934,0.00003710679,0.00009151171,0.000005993777,0.0000070199367,0.000004274822,0.00008304051,6.45324e-7,0.000040948235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960095,0.0001163282,0.000049761424,0.00009152169,0.000097240634,0.000044139942],"domain_scores_gemma":[0.99789006,0.0003818913,0.0011281125,0.00010060598,0.00016966101,0.00032975257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010270904,0.00034744764,0.00039377803,0.00052141235,0.00020542937,0.0005425018,0.00031157176,0.00039682875,0.00061795936],"category_scores_gemma":[0.0026682992,0.00017382287,0.00025249732,0.00042035457,0.0002272216,0.00041405315,0.00043619136,0.00040727077,0.00016432547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032159608,0.00002376527,0.99809664,0.000007116477,0.000036795805,0.00005267932,0.000018505129,0.000043404336,0.0004567586,0.000004080667,0.000026293766,0.0009122666],"study_design_scores_gemma":[0.000019919727,0.00047893685,0.9978853,0.0000076157257,0.00005052282,0.00056109874,0.000047224312,0.0005116571,0.000323514,0.000016167542,0.00009364103,0.000004410835],"about_ca_topic_score_codex":0.00051841635,"about_ca_topic_score_gemma":0.00047988238,"teacher_disagreement_score":0.0010270904,"about_ca_system_score_codex":0.00016142969,"about_ca_system_score_gemma":0.00020677292,"threshold_uncertainty_score":0.005431831},"labels":[],"label_agreement":null},{"id":"W4392468828","doi":"10.1136/lupus-2023-001140","title":"Systemic lupus in the era of machine learning medicine","year":2024,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"Lupus Foundation of America","keywords":"Artificial intelligence; Machine learning; Transformative learning; Big data; Field (mathematics); Medicine; Deep learning; Data science; Unsupervised learning; Artificial neural network; Computer science; Data mining; Psychology","score_opus":0.06226594203170679,"score_gpt":0.39420321932972147,"score_spread":0.3319372772980147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392468828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000489127,0.9979087,0.000093390925,0.0011690835,0.00023339217,0.0000019446732,0.000007369875,0.0000055432142,0.0005317871],"genre_scores_gemma":[0.0005112216,0.9978968,0.0001529607,0.00078499736,0.00039674397,0.000004078123,0.00001247112,0.0000013040556,0.00023942768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995616,0.00013264826,0.00006123146,0.000052910313,0.00016088216,0.000030765634],"domain_scores_gemma":[0.9986576,0.0008616004,0.00010122676,0.000037707392,0.00026722118,0.00007463865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011922432,0.0005528482,0.0012647863,0.0020628152,0.00030964633,0.0012826071,0.00064310245,0.0014429237,0.0028708118],"category_scores_gemma":[0.0019544964,0.0002223114,0.0005226954,0.0021027066,0.0007638202,0.0019831755,0.0008011887,0.003037171,0.0014111786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006232539,0.000040764327,0.00020752555,0.018340033,0.000119958786,0.00016465904,0.000093714276,0.0003316747,0.00053056236,0.011659283,0.052000377,0.9164491],"study_design_scores_gemma":[0.00001384903,0.0000522231,0.0006477958,0.008133612,0.00007932533,0.0008222865,0.00006320194,0.000094813855,0.00013656568,0.0068795653,0.98305976,0.000017131566],"about_ca_topic_score_codex":0.0011209185,"about_ca_topic_score_gemma":0.0018667466,"teacher_disagreement_score":0.0028708118,"about_ca_system_score_codex":0.0009795116,"about_ca_system_score_gemma":0.0018478772,"threshold_uncertainty_score":0.009603798},"labels":[],"label_agreement":null},{"id":"W4392905853","doi":"10.1136/lupus-2024-001167","title":"Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Belimumab; Breast milk; Human breast milk; Systemic lupus; Internal medicine; Systemic lupus erythematosus; Immunology; Disease; Antibody; B-cell activating factor","score_opus":0.02394762475132853,"score_gpt":0.3258363527269486,"score_spread":0.30188872797562005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392905853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723866,0.0068297414,0.002472638,0.0059522423,0.000544817,0.00016441736,0.000340644,0.0003542252,0.010954705],"genre_scores_gemma":[0.9935136,0.0012728813,0.0007267733,0.0013915056,0.00082629547,0.00001797534,0.000093907634,0.0000357049,0.0021213535],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99946433,0.00006841033,0.00005628198,0.00014896886,0.000098833174,0.000163188],"domain_scores_gemma":[0.9977685,0.00090318505,0.0004625829,0.0001964907,0.00011326874,0.00055600225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002772086,0.0020736875,0.0014344867,0.0022602472,0.0022710024,0.00161386,0.0018288672,0.006555648,0.0024492096],"category_scores_gemma":[0.0033326407,0.0017649343,0.0017552085,0.0011507093,0.001990651,0.0017458949,0.0012152466,0.00429596,0.001092841],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084325926,0.000029487916,0.0017592389,0.000016397446,0.0000060204325,0.99696344,0.00006367258,0.000024270028,0.0005571868,0.000037358604,0.00009648249,0.00036212953],"study_design_scores_gemma":[0.000024715231,0.00016815141,0.0035680467,0.000009244483,0.000047481288,0.9932012,0.00014846261,0.0003535956,0.0019160277,0.00008545425,0.000463093,0.000014461183],"about_ca_topic_score_codex":0.003073372,"about_ca_topic_score_gemma":0.0022530602,"teacher_disagreement_score":0.006555648,"about_ca_system_score_codex":0.0016659312,"about_ca_system_score_gemma":0.00084518304,"threshold_uncertainty_score":0.0120872855},"labels":[],"label_agreement":null},{"id":"W4394682282","doi":"10.1136/lupus-2023-001139","title":"Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; McGill University Health Centre; Mount Sinai Hospital; University Health Network; Dalhousie University; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Toronto Western Hospital; University of Calgary","funders":"LUPUS UK; National Center for Research Resources; Lupus Research Alliance; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Novo Nordisk Fonden; National Research Foundation; Wellcome Trust; University College London; Novo Nordisk; National Institute for Health and Care Research; Arthritis Society; Canadian Institutes of Health Research; Gigtforeningen; Johns Hopkins University; Manchester Biomedical Research Centre; Université Laval; Sandwell and West Birmingham Hospitals NHS Trust; National Center for Advancing Translational Sciences; National Research Foundation of Korea; Eusko Jaurlaritza; Singer Family Foundation; National Institutes of Health; Canada Research Chairs; Lupus Foundation of America","keywords":"Medicine; Autoantibody; Dermatology; Systemic lupus erythematosus; Immunology; Pathology; Disease; Antibody","score_opus":0.016069976361661804,"score_gpt":0.26898091664084756,"score_spread":0.25291094027918576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394682282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991634,0.00033233827,0.000060967337,0.000037357477,0.000004514032,0.00000345768,0.00008372463,0.000004936742,0.0003093438],"genre_scores_gemma":[0.99968064,0.00009321272,0.000055683166,0.000016470889,0.000009051015,0.0000023779762,0.000088267014,0.0000014225569,0.000052911924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926347,0.00014089626,0.0000941653,0.00018374601,0.0002177307,0.00010006326],"domain_scores_gemma":[0.99598604,0.00057728647,0.0025990803,0.00013891868,0.00025634823,0.00044223483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008386748,0.00048380613,0.0004340324,0.0012173755,0.00055216043,0.0006840807,0.0006375885,0.00063167524,0.0023310804],"category_scores_gemma":[0.0033331001,0.00037060629,0.00038603653,0.0013080301,0.00045239882,0.00043299847,0.0005348922,0.00067973015,0.00030624133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095134055,0.000018367347,0.99810386,0.00000838089,0.000025805584,0.00052224996,0.000029948622,0.000028612,0.00024732627,0.000011503072,0.000060380404,0.00084848807],"study_design_scores_gemma":[0.000008637468,0.00004731794,0.99636936,0.000008911005,0.000029601748,0.00312383,0.000048429567,0.00017873295,0.00005578804,0.000025969668,0.00010053806,0.0000028278998],"about_ca_topic_score_codex":0.0029165319,"about_ca_topic_score_gemma":0.002837103,"teacher_disagreement_score":0.0029165319,"about_ca_system_score_codex":0.0004350224,"about_ca_system_score_gemma":0.00037858463,"threshold_uncertainty_score":0.0077982545},"labels":[],"label_agreement":null},{"id":"W4398224743","doi":"10.1136/lupus-2023-001124","title":"Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council","keywords":"Medicine; Hydroxychloroquine; Belimumab; Disease; Systemic lupus erythematosus; Clinical trial; Observational study; Internal medicine; Intensive care medicine; Immunology; Infectious disease (medical specialty)","score_opus":0.04663422267112665,"score_gpt":0.3599405578604351,"score_spread":0.31330633518930845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398224743","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072087545,0.9983015,0.00011290497,0.00016799208,0.000095605414,0.00002950804,0.000037295507,0.0000032272612,0.0005310192],"genre_scores_gemma":[0.018243019,0.9783125,0.001455394,0.0010676167,0.00024000298,0.000098228644,0.00013017785,0.000002373881,0.00045066702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99796814,0.00078479864,0.0005764578,0.00011778779,0.0004833962,0.000069376336],"domain_scores_gemma":[0.9975331,0.0014459984,0.00067631865,0.000053125546,0.00025288164,0.00003858307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021455318,0.0004478464,0.0012669964,0.0027033363,0.00022255085,0.00093811465,0.00044534195,0.00057487685,0.0016256364],"category_scores_gemma":[0.0042247274,0.00015311906,0.0016474263,0.0017501093,0.0003222589,0.00067519327,0.0004291166,0.00076032605,0.00030774248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032277105,0.0000811886,0.001801362,0.14012472,0.001386796,0.00026179772,0.00022741455,0.0002509517,0.0016778128,0.002886246,0.007896622,0.8430823],"study_design_scores_gemma":[0.0006472604,0.0018754643,0.030802172,0.19300592,0.009208551,0.0045696646,0.00038427548,0.00043095255,0.002173673,0.00528997,0.7515378,0.00007421716],"about_ca_topic_score_codex":0.0011171662,"about_ca_topic_score_gemma":0.0032597464,"teacher_disagreement_score":0.0027033363,"about_ca_system_score_codex":0.0006227096,"about_ca_system_score_gemma":0.0018571032,"threshold_uncertainty_score":0.011346757},"labels":[],"label_agreement":null},{"id":"W4398785205","doi":"10.1136/lupus-2024-001158","title":"Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Saudi Heart Association; King Saud University","keywords":"Medicine; Mace; Internal medicine; Cohort; Population; Epidemiology; Systemic lupus erythematosus; Prospective cohort study; Myocardial infarction; Cohort study; Diabetes mellitus; Stroke (engine); Disease; Environmental health; Percutaneous coronary intervention; Endocrinology","score_opus":0.012827992643167299,"score_gpt":0.26437991370976266,"score_spread":0.25155192106659535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398785205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610955,0.00051667687,0.00011521992,0.000038415266,0.0000072554762,0.000016007101,0.0028257314,0.000005671804,0.0003655563],"genre_scores_gemma":[0.99468344,0.0005217765,0.00021584188,0.00003638582,0.0000160038,0.000022145077,0.0043630735,0.0000024431115,0.000138863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952304,0.000108058724,0.00009805792,0.00010011981,0.00012679126,0.000043921773],"domain_scores_gemma":[0.99784374,0.00016358912,0.0009844457,0.000184024,0.00060930295,0.00021494202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001143857,0.0002864414,0.00027355886,0.0013080761,0.00020242028,0.0005324873,0.00032497232,0.00021666859,0.00081436627],"category_scores_gemma":[0.0023649007,0.0001653181,0.00044995622,0.0010841122,0.00012553224,0.00035616316,0.00068639184,0.00026650736,0.00015511808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008571485,0.000008698503,0.9976847,0.00002639044,0.000081442224,0.000018439545,0.00006994622,0.00002598667,0.00011334707,0.000008630958,0.00013785796,0.0017388689],"study_design_scores_gemma":[0.0000060649077,0.000034256194,0.9992543,0.000011982229,0.000029536148,0.00012570251,0.00014209322,0.000083241,0.000039880397,0.0000055790547,0.0002643638,0.000002919857],"about_ca_topic_score_codex":0.016238848,"about_ca_topic_score_gemma":0.01811608,"teacher_disagreement_score":0.016238848,"about_ca_system_score_codex":0.0003666682,"about_ca_system_score_gemma":0.0003477618,"threshold_uncertainty_score":0.03228861},"labels":[],"label_agreement":null},{"id":"W4400598652","doi":"10.1136/lupus-2023-001006","title":"Outcome clusters and their stability over 1 year in patients with SLE: self-reported and performance-based cognitive function, disease activity, mood and health-related quality of life","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; Hospital for Sick Children; Institute for Work & Health; Toronto Western Hospital; University of Toronto; University Health Network; University of Calgary","funders":"Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation; Lupus Research Alliance","keywords":"Medicine; Quality of life (healthcare); Beck Depression Inventory; Mood; Anxiety; Depression (economics); Cluster (spacecraft); Cognition; Neuropsychology; Disease; Internal medicine; Physical therapy; Clinical psychology; Psychiatry","score_opus":0.04869110732653753,"score_gpt":0.3321693120228462,"score_spread":0.2834782046963087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400598652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995882,0.00012589127,0.000039984225,0.000015248955,0.000001973443,0.000008575141,0.00010614076,0.0000018902011,0.00011216377],"genre_scores_gemma":[0.9997284,0.000019382722,0.00003084051,0.0000048576135,0.0000041573503,0.0000064747146,0.00016921244,5.9650796e-7,0.000035960602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932003,0.00018138831,0.00010590958,0.00013194117,0.00013630454,0.00012444638],"domain_scores_gemma":[0.99669516,0.00046955902,0.0019426428,0.00011291793,0.00032641,0.00045338352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010196728,0.00029024636,0.00047166416,0.0009998102,0.00071719236,0.0006489148,0.00030628746,0.0004923168,0.0010187479],"category_scores_gemma":[0.0035764854,0.00019002665,0.0005501964,0.0009518375,0.00036012832,0.00070520025,0.00064873794,0.00060215435,0.00016693794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002448274,0.000026122469,0.99852544,0.000006988592,0.000035183384,0.00008221873,0.00009998783,0.000044504097,0.00010432061,0.00000425079,0.000030897958,0.00079517526],"study_design_scores_gemma":[0.000008783549,0.00020065278,0.9991722,0.0000024259361,0.000018313647,0.00028887912,0.0001410306,0.00009373068,0.000032267926,0.000009708362,0.000028112421,0.0000039135807],"about_ca_topic_score_codex":0.0022276137,"about_ca_topic_score_gemma":0.002689227,"teacher_disagreement_score":0.0022276137,"about_ca_system_score_codex":0.000506528,"about_ca_system_score_gemma":0.00034771638,"threshold_uncertainty_score":0.005392611},"labels":[],"label_agreement":null},{"id":"W4400659784","doi":"10.1136/lupus-2024-001201","title":"Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Center, University of Rochester; University of California, Irvine; Northwell Health; Hospital for Special Surgery; McMaster University; Brigham and Women's Hospital; McGill University; McGill University Health Centre; University of Rochester; University of Miami; Vanderbilt University","keywords":"Medicine; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Omega 3 fatty acid; Placebo-controlled study; Randomized controlled trial; Polyunsaturated fatty acid; Fatty acid; Double blind; Docosahexaenoic acid; Pathology; Biochemistry","score_opus":0.014293200541344076,"score_gpt":0.27999612888777786,"score_spread":0.2657029283464338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400659784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842218,0.008637948,0.00048879645,0.0006434466,0.0007478211,0.0038891823,0.00041151798,0.000102162936,0.00085732306],"genre_scores_gemma":[0.98814464,0.0034579593,0.0013607469,0.000821389,0.0007414547,0.0036265203,0.00036256365,0.000014497802,0.0014702227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99895716,0.0005281222,0.00012751656,0.00016846767,0.000096756696,0.00012187946],"domain_scores_gemma":[0.9987035,0.0004065252,0.0003299471,0.00009238557,0.00010481963,0.00036293804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022667255,0.001499263,0.0046027536,0.0005407909,0.0006863369,0.001009825,0.0009806196,0.0027450926,0.0049848803],"category_scores_gemma":[0.0024057317,0.00081366464,0.002147553,0.00048790616,0.0011499044,0.0009326115,0.00047818854,0.0021469195,0.0007127815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9874794,0.0030884973,0.00030348235,0.00071776984,0.0006510303,0.000032127773,0.00003480376,0.00006205921,0.0018106013,0.000020375684,0.00016077512,0.0056391163],"study_design_scores_gemma":[0.95281154,0.04535859,0.00095969526,0.00003072357,0.00035073422,0.000016922035,0.000009807836,0.00010882619,0.00016213818,0.000019465908,0.00016417008,0.0000074733716],"about_ca_topic_score_codex":0.00081987976,"about_ca_topic_score_gemma":0.001407398,"teacher_disagreement_score":0.0049848803,"about_ca_system_score_codex":0.00056939124,"about_ca_system_score_gemma":0.0011410101,"threshold_uncertainty_score":0.016676128},"labels":[],"label_agreement":null},{"id":"W4400996030","doi":"10.1136/lupus-2024-001155","title":"Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review","year":2024,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; University of Waterloo","funders":"Social Sciences and Humanities Research Council; Social Sciences and Humanities Research Council of Canada; University of Waterloo; Canadian Institutes of Health Research; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Biopsychosocial model; Psychiatry","score_opus":0.19514197554806903,"score_gpt":0.4872690611320009,"score_spread":0.29212708558393186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400996030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005603003,0.99610376,0.00056406367,0.0014329904,0.00027241893,0.0003048068,0.00011477367,0.000006061749,0.0006407944],"genre_scores_gemma":[0.004606405,0.99211496,0.00135127,0.00076511083,0.00015010432,0.0007438211,0.00013325087,0.0000039701354,0.0001310416],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9894907,0.0040533547,0.0038093817,0.0006863358,0.0016683151,0.0002919537],"domain_scores_gemma":[0.93134326,0.056475647,0.0060404353,0.0008703927,0.0047932384,0.00047696225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020129723,0.0015799316,0.0057234317,0.0258536,0.001592073,0.0068112887,0.0025143023,0.0043277713,0.004035363],"category_scores_gemma":[0.081675276,0.0015442998,0.006195312,0.017459793,0.0020932108,0.007853648,0.0040017124,0.0031884385,0.00055179506],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087881264,0.000049062928,0.0016972844,0.77594984,0.0029025984,0.00028529565,0.0026182223,0.00035178193,0.0003095622,0.004759444,0.0058164466,0.20517257],"study_design_scores_gemma":[0.000015609245,0.00002562636,0.0012698103,0.9729997,0.0036575175,0.00015613675,0.00068559096,0.00007959269,0.00004328411,0.0011229133,0.019926159,0.000018064406],"about_ca_topic_score_codex":0.01001046,"about_ca_topic_score_gemma":0.020182397,"teacher_disagreement_score":0.0258536,"about_ca_system_score_codex":0.005533881,"about_ca_system_score_gemma":0.025927378,"threshold_uncertainty_score":0.10645741},"labels":[],"label_agreement":null},{"id":"W4401664947","doi":"10.1136/lupus-2024-001214","title":"Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction","year":2024,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Lupus Research Alliance; Lupus Foundation of America","keywords":"Neuroimaging; Medicine; Neurocognitive; Cognition; Diffusion MRI; Magnetic resonance imaging; Corpus callosum; Systematic review; Pathology; Radiology; MEDLINE; Psychiatry","score_opus":0.036396661289612706,"score_gpt":0.3278979878338299,"score_spread":0.2915013265442172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401664947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015056777,0.99775535,0.000076995464,0.00012472118,0.000048097965,0.00008211366,0.000298075,0.000004126082,0.000104985906],"genre_scores_gemma":[0.020704104,0.97785425,0.00045061015,0.00032894264,0.00008631746,0.00026463546,0.00023787712,0.0000043009413,0.000068891306],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943456,0.0016918734,0.0024653426,0.000572269,0.00076478877,0.00016017974],"domain_scores_gemma":[0.96592593,0.02489167,0.006084736,0.00041464134,0.0023447643,0.0003382281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006582303,0.0016667703,0.008908394,0.011425635,0.00056769676,0.0019457614,0.0014726325,0.0016064284,0.0031881537],"category_scores_gemma":[0.025960902,0.00087032386,0.0076367627,0.011522581,0.0009018682,0.0016132917,0.0012987909,0.00080677064,0.00020918544],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026177583,0.000012477662,0.0019949516,0.9533863,0.015886443,0.00017247399,0.00015422417,0.000082601044,0.00018019356,0.00010927207,0.00081475725,0.026944483],"study_design_scores_gemma":[0.00034201008,0.0003700219,0.01794393,0.7765389,0.18778029,0.0010615024,0.0003431339,0.00011705855,0.0003105062,0.0003260237,0.014804434,0.000062196304],"about_ca_topic_score_codex":0.007348748,"about_ca_topic_score_gemma":0.021989651,"teacher_disagreement_score":0.011425635,"about_ca_system_score_codex":0.0024452866,"about_ca_system_score_gemma":0.0069287424,"threshold_uncertainty_score":0.03481096},"labels":[],"label_agreement":null},{"id":"W4403639509","doi":"10.1136/lupus-2024-001282","title":"Improving routine mental health screening for depression and anxiety in a paediatric lupus clinic: a quality improvement initiative for enhanced mental healthcare","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; University of Calgary; University of Alberta Hospital; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Anxiety; Referral; Mental health; Psychological intervention; Depression (economics); Patient Health Questionnaire; Patient satisfaction; Psychiatry; Family medicine; Depressive symptoms; Nursing","score_opus":0.06223077290842325,"score_gpt":0.42240224509626867,"score_spread":0.3601714721878454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403639509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76363754,0.013094132,0.036998767,0.14310797,0.0014974754,0.015766632,0.0024894644,0.0024144943,0.020993512],"genre_scores_gemma":[0.82764053,0.0069507197,0.14809045,0.009541671,0.00051111163,0.004525193,0.0017620692,0.000108429784,0.0008697597],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.971227,0.018553521,0.0021328432,0.0011051662,0.0047385804,0.0022428085],"domain_scores_gemma":[0.94744146,0.009385002,0.014006001,0.0029343953,0.006468565,0.019764544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045405097,0.00073666155,0.0007429134,0.0015387359,0.0013970495,0.0034933947,0.0023561656,0.000881854,0.0027526766],"category_scores_gemma":[0.049908187,0.00044425798,0.0018027732,0.0019687908,0.0010994739,0.0022848502,0.0057287007,0.0025567573,0.00038169176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009124857,0.005327642,0.31623596,0.0038333659,0.00062185363,0.00029416112,0.0033938154,0.002287146,0.0015606756,0.0011252908,0.03108873,0.63331884],"study_design_scores_gemma":[0.0035999524,0.011127179,0.92700106,0.005772357,0.0008749629,0.0007368101,0.007037531,0.008051016,0.0018733052,0.0015002649,0.032302503,0.00012307732],"about_ca_topic_score_codex":0.006655151,"about_ca_topic_score_gemma":0.011993447,"teacher_disagreement_score":0.045405097,"about_ca_system_score_codex":0.0057976926,"about_ca_system_score_gemma":0.03208595,"threshold_uncertainty_score":0.24012804},"labels":[],"label_agreement":null},{"id":"W4404194139","doi":"10.1136/lupus-2024-001265","title":"Using photovoice to investigate patient experiences of lupus nephritis in Canada","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Waterloo","funders":"","keywords":"Medicine; Lupus nephritis; Photovoice; Systemic lupus erythematosus; Intensive care medicine; Family medicine; Internal medicine; Disease","score_opus":0.044316908971594536,"score_gpt":0.3302206110851214,"score_spread":0.2859037021135269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404194139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913754,0.00064887595,0.00023319315,0.0012775951,0.00004461452,0.0002168057,0.00034644824,0.000010782392,0.0058462285],"genre_scores_gemma":[0.99677545,0.0004685188,0.00052579417,0.00059080555,0.000008396095,0.00012545096,0.000100645535,0.000007673386,0.0013972688],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9978454,0.0009587603,0.00007089466,0.00020806403,0.00032771545,0.00058918446],"domain_scores_gemma":[0.9955973,0.0015081445,0.0005488169,0.00014095336,0.0008571627,0.0013476693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002169317,0.0002825088,0.00038274424,0.0009797983,0.010125411,0.0022976878,0.0013324191,0.00084399513,0.00393137],"category_scores_gemma":[0.005101619,0.0003018369,0.00043520535,0.0012157677,0.0028178913,0.0008759804,0.0034955137,0.0015640365,0.00017429437],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024107067,0.00017480673,0.0508932,0.00046682212,0.000030728832,0.0016364862,0.9193678,0.00011738856,0.0014889297,0.000502701,0.0050426507,0.020037387],"study_design_scores_gemma":[0.000027916234,0.00017973824,0.04857433,0.00032184873,0.000021451753,0.00061862654,0.92270386,0.0002207241,0.00033622305,0.00016677774,0.026767397,0.00006107214],"about_ca_topic_score_codex":0.7824108,"about_ca_topic_score_gemma":0.9186554,"teacher_disagreement_score":0.2175892,"about_ca_system_score_codex":0.022195728,"about_ca_system_score_gemma":0.024770955,"threshold_uncertainty_score":0.43774122},"labels":[],"label_agreement":null},{"id":"W4404200078","doi":"10.1136/lupus-2024-001319","title":"Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"Biogen; Gilead Sciences; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Glucocorticoid; Aura; Immunosuppression; Internal medicine; Oncology; Pharmacology","score_opus":0.0701455160289588,"score_gpt":0.3948763619322465,"score_spread":0.3247308459032877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404200078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97388375,0.01942785,0.0031631696,0.0002926633,0.00013520905,0.0004586858,0.0013812488,0.000019698022,0.0012376712],"genre_scores_gemma":[0.99815065,0.00051503174,0.00041714328,0.00010194294,0.000052344873,0.0001794164,0.00044762206,0.000006844141,0.00012888356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9819527,0.010229536,0.0028645536,0.0027453988,0.0016246864,0.00058316864],"domain_scores_gemma":[0.97770077,0.011484844,0.0077089802,0.0017111315,0.0007298228,0.00066434516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016029561,0.00057783833,0.0016606885,0.0014863472,0.00037928674,0.0015306597,0.00085957773,0.00093562336,0.0038282825],"category_scores_gemma":[0.017637877,0.00036430568,0.0074846535,0.0016453447,0.000527114,0.00067229324,0.0011551445,0.000814912,0.00021094059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08473463,0.00034050294,0.76368695,0.0030282259,0.12199,0.00026141622,0.0002937797,0.0015644466,0.0019568335,0.00077812525,0.0010448335,0.020320235],"study_design_scores_gemma":[0.009272066,0.013842631,0.8392603,0.0007385176,0.118240766,0.00083938707,0.00060196884,0.008127812,0.0011996375,0.0019796267,0.005815123,0.00008208803],"about_ca_topic_score_codex":0.00060351036,"about_ca_topic_score_gemma":0.0006734071,"teacher_disagreement_score":0.016029561,"about_ca_system_score_codex":0.00042668797,"about_ca_system_score_gemma":0.0005589102,"threshold_uncertainty_score":0.08477348},"labels":[],"label_agreement":null},{"id":"W4404604186","doi":"10.1136/lupus-2024-001272","title":"Myocardial Performance Index to assess cardiac function in autoimmune connective tissue disease: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fakultas Kedokteran, Universitas Indonesia; Universitas Sumatera Utara; Universitas Indonesia","keywords":"Medicine; Polymyositis; Dermatomyositis; Mixed connective tissue disease; Internal medicine; Rheumatoid arthritis; Cochrane Library; Rheumatology; Pathology; Meta-analysis","score_opus":0.08536034491586028,"score_gpt":0.3736160358517058,"score_spread":0.28825569093584547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404604186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037071751,0.9950997,0.0003332125,0.00014179153,0.0000818026,0.00015776091,0.00031280753,0.000011451761,0.0001543089],"genre_scores_gemma":[0.20848447,0.7853704,0.0025051625,0.00086181756,0.00039038464,0.0013003697,0.0007940223,0.000022990767,0.0002703908],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922267,0.003664019,0.0019934364,0.00089443324,0.0009431056,0.00027830494],"domain_scores_gemma":[0.98101383,0.0142167425,0.003129984,0.00042298346,0.000987876,0.00022865833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011360986,0.0023716763,0.015107177,0.0070975646,0.00060507463,0.0030076941,0.0018123604,0.002156758,0.0032160303],"category_scores_gemma":[0.028278498,0.0011311322,0.028198136,0.007336476,0.00068563607,0.0015418835,0.0013155662,0.0015351395,0.00019587162],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014436811,0.00003297534,0.011353796,0.44699666,0.5246054,0.0001253163,0.0000812296,0.00054957665,0.00017518073,0.0001367216,0.00055928633,0.013940126],"study_design_scores_gemma":[0.0005228999,0.000266784,0.010347663,0.03929604,0.9473179,0.00013853222,0.000051802057,0.0003046426,0.00008915884,0.00019546182,0.0014402318,0.000028850725],"about_ca_topic_score_codex":0.0057766167,"about_ca_topic_score_gemma":0.0121754,"teacher_disagreement_score":0.015107177,"about_ca_system_score_codex":0.002134095,"about_ca_system_score_gemma":0.003031652,"threshold_uncertainty_score":0.06008339},"labels":[],"label_agreement":null},{"id":"W4404828176","doi":"10.1136/lupus-2024-001264","title":"Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"Lupus Research Alliance; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Lupus nephritis; Internal medicine; Renal function; Renal biopsy; Systemic lupus erythematosus; Cohort; Retrospective cohort study; End stage renal disease; Gastroenterology; Urology; Hemodialysis; Disease","score_opus":0.01648746074488312,"score_gpt":0.29969035967926805,"score_spread":0.28320289893438494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404828176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803275,0.00017160573,0.000037554288,0.000050148014,0.000003644518,0.0000075543617,0.001424362,0.0000028544237,0.00026942306],"genre_scores_gemma":[0.9984364,0.00009264148,0.00003805038,0.000019691148,0.000008132877,0.000005564397,0.0012015379,0.0000018810571,0.00019619477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952424,0.000078973455,0.000047010908,0.00013768657,0.00010962506,0.00010239133],"domain_scores_gemma":[0.99760485,0.00020061123,0.0008656823,0.00023099947,0.00040539543,0.00069241674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073511247,0.00031957266,0.00031909833,0.0006185468,0.00061611924,0.0008919949,0.0004790896,0.00030549715,0.0015233713],"category_scores_gemma":[0.0025966836,0.00023137758,0.00046324916,0.0010666944,0.0003588139,0.00033512578,0.0007814718,0.0004009446,0.00024401238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010078443,0.0000052482633,0.9990368,0.000005548163,0.000038267062,0.00004321266,0.00011530961,0.00003385208,0.000106426734,0.000007681653,0.00014277236,0.00036417926],"study_design_scores_gemma":[0.0000062331783,0.000020733518,0.9995054,0.000003722991,0.000024268596,0.000056955032,0.00011985052,0.0000969653,0.00001785896,0.00000378087,0.00014183456,0.0000024614112],"about_ca_topic_score_codex":0.35009658,"about_ca_topic_score_gemma":0.41593406,"teacher_disagreement_score":0.35009658,"about_ca_system_score_codex":0.0019085021,"about_ca_system_score_gemma":0.0014178845,"threshold_uncertainty_score":0.6961176},"labels":[],"label_agreement":null},{"id":"W4404867619","doi":"10.1136/lupus-2024-001347","title":"Interferon-α as a biomarker to predict renal outcomes in lupus nephritis","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Toronto Western Hospital; University of Toronto; University Health Network","funders":"University of Toronto; Pfizer; Lupus Foundation of America","keywords":"Medicine; Lupus nephritis; Renal function; Internal medicine; Systemic lupus erythematosus; Urology; Adverse effect; End stage renal disease; Gastroenterology; Hemodialysis; Disease","score_opus":0.03131151164403084,"score_gpt":0.35724130831379297,"score_spread":0.32592979666976213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404867619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967638,0.0022532444,0.0003571468,0.00009860928,0.000023186933,0.000013266361,0.00016182866,0.000007264002,0.00032151537],"genre_scores_gemma":[0.99923754,0.00021917085,0.00026403237,0.000025071053,0.00003164352,0.0000097233415,0.00012441141,0.0000010106197,0.00008728937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943024,0.0002592307,0.0000731846,0.00007711324,0.000108253946,0.00005196598],"domain_scores_gemma":[0.9973225,0.0006036373,0.0014456994,0.00007274749,0.00022771378,0.00032775494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015829931,0.0004611344,0.0006225689,0.0006245884,0.00018683866,0.0007113473,0.0002866843,0.0005664409,0.00076754723],"category_scores_gemma":[0.0036141323,0.00014161457,0.00033998175,0.0006843931,0.00018836824,0.0004424289,0.00034891014,0.00060657295,0.00022292101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064571796,0.00004265872,0.9957253,0.000019228966,0.000104015264,0.000043272026,0.000011728251,0.00014502865,0.00046940194,0.0000080255395,0.00005289628,0.0027326874],"study_design_scores_gemma":[0.00007094561,0.0009039635,0.99490935,0.000047520505,0.00018884416,0.00060879637,0.000054983728,0.0022156911,0.0005468372,0.00009142538,0.00035303048,0.0000085183],"about_ca_topic_score_codex":0.0003203108,"about_ca_topic_score_gemma":0.0004081003,"teacher_disagreement_score":0.0015829931,"about_ca_system_score_codex":0.00020502684,"about_ca_system_score_gemma":0.00025732518,"threshold_uncertainty_score":0.00837177},"labels":[],"label_agreement":null},{"id":"W4405384792","doi":"10.1136/lupus-2024-001174","title":"Non-criteria antiphospholipid antibody profiles and thrombotic outcomes in a cohort of patients with systemic lupus erythematosus","year":2024,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Calgary","funders":"Arthritis Society; LEO Pharma; University of Calgary; CSL Behring; Sanofi","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Internal medicine; Rheumatology; Autoantibody; Thrombosis; Cohort; Univariate analysis; Systemic lupus erythematosus; Immunology; Gastroenterology; Antibody; Multivariate analysis; Disease","score_opus":0.013353859100238409,"score_gpt":0.318518743806899,"score_spread":0.3051648847066606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405384792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994711,0.00015733154,0.000014461055,0.000038067446,0.0000030840322,0.0000032851337,0.00010757418,0.0000013751902,0.0002037931],"genre_scores_gemma":[0.9996996,0.000060696446,0.000013466308,0.000015866628,0.000005771314,0.0000022283418,0.00014105969,5.1816994e-7,0.00006091663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996197,0.0000816152,0.000033200322,0.0000794471,0.000098386095,0.00008745777],"domain_scores_gemma":[0.99875295,0.00019398236,0.00059046515,0.000059647922,0.000102287835,0.0003007017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046989587,0.0002864332,0.00029914425,0.0006705946,0.0005173168,0.00077353674,0.00039540476,0.0004595816,0.0016684263],"category_scores_gemma":[0.001837584,0.00024699396,0.0002938504,0.0008940762,0.00033580218,0.0003936938,0.00034774156,0.00055845466,0.00021367252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059911577,0.00001773684,0.999373,0.0000028819825,0.000018060313,0.00009856802,0.000029846959,0.000016665204,0.000068857,0.0000062495533,0.00003389142,0.00027443585],"study_design_scores_gemma":[0.000009701631,0.000049405495,0.99919194,0.0000038556545,0.00001381971,0.00045910446,0.00009466872,0.00009603965,0.0000144415,0.000012243829,0.00005271847,0.0000019217816],"about_ca_topic_score_codex":0.015232891,"about_ca_topic_score_gemma":0.01465503,"teacher_disagreement_score":0.015232891,"about_ca_system_score_codex":0.00048273863,"about_ca_system_score_gemma":0.0005457204,"threshold_uncertainty_score":0.030288458},"labels":[],"label_agreement":null},{"id":"W4406810389","doi":"10.1136/lupus-2024-001336","title":"Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Chugai Pharmaceutical; EMD Serono; Genentech; Grifols; Medac; Alexion Pharmaceuticals; Sanofi; Biogen; GlaxoSmithKline; Servier; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Systemic lupus erythematosus; Observational study; Cohort; Glucocorticoid; Prospective cohort study; Demographics; Population; Cohort study; Disease","score_opus":0.03152789944054337,"score_gpt":0.35656425635319106,"score_spread":0.3250363569126477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406810389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839896,0.0001928103,0.00007795235,0.000028173674,0.000006088355,0.000011938829,0.0011591457,0.0000024587591,0.00012248511],"genre_scores_gemma":[0.99814844,0.00006495768,0.00008188758,0.000026838597,0.00001115102,0.0000175429,0.0016070144,0.0000025684474,0.000039662795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981186,0.0007016719,0.00026713172,0.00047850117,0.00023716039,0.00019699275],"domain_scores_gemma":[0.99573237,0.00074004015,0.002024544,0.00056040287,0.00032576427,0.00061687623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026378178,0.00033871602,0.0006711774,0.0009911965,0.0005039503,0.00090005423,0.00055994326,0.0006899143,0.00092146086],"category_scores_gemma":[0.004031622,0.0003815017,0.0010116141,0.0017039721,0.00034084162,0.0005938536,0.0009282668,0.0007689738,0.000205899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021109199,0.00001746467,0.9991891,0.000005377868,0.00012510199,0.00002492801,0.000033935376,0.000025038322,0.0000674984,0.000008856532,0.00006413301,0.00022749274],"study_design_scores_gemma":[0.000024731931,0.0000977091,0.9992078,0.0000046769496,0.000043571625,0.00014297027,0.0001329281,0.00019364733,0.000016259306,0.00001032475,0.00012009156,0.0000053270614],"about_ca_topic_score_codex":0.0063148076,"about_ca_topic_score_gemma":0.006121609,"teacher_disagreement_score":0.0063148076,"about_ca_system_score_codex":0.00037583933,"about_ca_system_score_gemma":0.00051638205,"threshold_uncertainty_score":0.013950288},"labels":[],"label_agreement":null},{"id":"W4406967580","doi":"10.1136/lupus-2024-001362","title":"Medication-related hospitalisations in patients with SLE","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Polypharmacy; Pediatrics; Internal medicine; Prospective cohort study; Logistic regression; Prednisone; Generalized estimating equation; Cohort; Emergency medicine","score_opus":0.010437438820278365,"score_gpt":0.28916528287697635,"score_spread":0.278727844056698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406967580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701,0.0015859248,0.00018446601,0.0000976642,0.000012585614,0.000018691662,0.0006797437,0.0000066910893,0.00040426038],"genre_scores_gemma":[0.99891376,0.0003338593,0.00010903257,0.00003484734,0.000019888164,0.000019191342,0.00046123928,0.000001393976,0.00010682299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984547,0.000599578,0.00024225509,0.00030708287,0.00018488592,0.00021153333],"domain_scores_gemma":[0.995806,0.00055439986,0.0030132409,0.00012120926,0.00020583202,0.00029932364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011155917,0.00027127643,0.00044046075,0.0008220083,0.00037558537,0.00065516564,0.00037225673,0.0004753153,0.0022436695],"category_scores_gemma":[0.00400253,0.00024166581,0.0009342676,0.0011844718,0.00020454181,0.00058074726,0.00078498496,0.000839244,0.00024559698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007651426,0.00001582733,0.9983046,0.000027433402,0.00005001469,0.00007061582,0.000076288095,0.000042765674,0.00004733941,0.000009130267,0.000060712588,0.0012187265],"study_design_scores_gemma":[0.000008793242,0.00011162669,0.9989002,0.000045601493,0.000024589417,0.00037278514,0.00018503264,0.00013922286,0.000027742655,0.000031446416,0.00014808527,0.0000048057195],"about_ca_topic_score_codex":0.004129491,"about_ca_topic_score_gemma":0.0051211556,"teacher_disagreement_score":0.004129491,"about_ca_system_score_codex":0.0004179404,"about_ca_system_score_gemma":0.0005368523,"threshold_uncertainty_score":0.008210897},"labels":[],"label_agreement":null},{"id":"W4408097983","doi":"10.1136/lupus-2024-001452","title":"Meeting report: The Systemic Lupus International Collaborating Clinics (SLICC) World Lupus Seminar on Africa","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Systemic lupus; Systemic lupus erythematosus; Representation (politics); Family medicine; Disease; Pathology; Political science","score_opus":0.03095477881955374,"score_gpt":0.36232051351116357,"score_spread":0.33136573469160985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408097983","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009195549,0.01803342,0.0022204632,0.45071784,0.43595558,0.0017770516,0.0035557663,0.00025400575,0.07829031],"genre_scores_gemma":[0.07245298,0.037007168,0.0061187567,0.20921184,0.30696377,0.0036738843,0.0049058287,0.0005799759,0.35908574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987676,0.0003112037,0.000074908945,0.00021182295,0.00030695536,0.0003276085],"domain_scores_gemma":[0.9970824,0.00035251703,0.00015394263,0.000058966532,0.0010443752,0.0013078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004204767,0.0014236389,0.00062320236,0.00078312564,0.0016031213,0.0023079945,0.001035472,0.0037916126,0.046311293],"category_scores_gemma":[0.0048746057,0.00033530698,0.0010208198,0.00033797216,0.0004740845,0.001659098,0.0023564245,0.0053089154,0.012358592],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113184076,0.00005066981,0.00040455174,0.00014864009,0.0000098180235,0.0004823645,0.0001662732,0.000043050957,0.00041590948,0.00036044323,0.9873279,0.010477144],"study_design_scores_gemma":[0.00009123056,0.00011776717,0.0020130535,0.0004159774,0.000015977972,0.00045007703,0.000564335,0.00009576293,0.00025207037,0.0004931294,0.99546957,0.000020926434],"about_ca_topic_score_codex":0.0024535859,"about_ca_topic_score_gemma":0.0038447878,"teacher_disagreement_score":0.046311293,"about_ca_system_score_codex":0.001855497,"about_ca_system_score_gemma":0.004120122,"threshold_uncertainty_score":0.15492672},"labels":[],"label_agreement":null},{"id":"W4410510213","doi":"10.1136/lupus-2024-001483","title":"Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Concordance; Placebo; Systemic lupus erythematosus; Internal medicine; Clinical trial; Post-hoc analysis; Disease; Pathology; Alternative medicine","score_opus":0.07079502131388452,"score_gpt":0.37536640799392396,"score_spread":0.30457138668003947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410510213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618611,0.02613635,0.0022971868,0.0006743014,0.00032769534,0.002490324,0.0017152462,0.000053713895,0.004444044],"genre_scores_gemma":[0.9933955,0.0011353253,0.0013945145,0.000377062,0.00027168682,0.0019668422,0.0010592822,0.000020139172,0.0003796115],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.8800722,0.090345174,0.0141420495,0.0049553085,0.009335676,0.0011496159],"domain_scores_gemma":[0.8131361,0.11506526,0.052449964,0.009680039,0.008050396,0.0016182348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.095810555,0.00087064743,0.0039623324,0.0010188902,0.00071207946,0.0017883417,0.0010404057,0.0019740467,0.0023394278],"category_scores_gemma":[0.10449202,0.000652712,0.0037112618,0.000981529,0.0013199188,0.0012204836,0.0016016085,0.0018322128,0.00035107962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7229754,0.00076548936,0.1616788,0.010810837,0.029327402,0.00023351818,0.0022980587,0.0011894308,0.0047882865,0.00071709626,0.0016846043,0.06353103],"study_design_scores_gemma":[0.158705,0.099480234,0.66644126,0.003168022,0.04092081,0.001283088,0.0009294065,0.0038654539,0.007636087,0.0024223975,0.014796526,0.00035172157],"about_ca_topic_score_codex":0.00032101394,"about_ca_topic_score_gemma":0.0006637733,"teacher_disagreement_score":0.095810555,"about_ca_system_score_codex":0.0006156878,"about_ca_system_score_gemma":0.0009216334,"threshold_uncertainty_score":0.5067007},"labels":[],"label_agreement":null},{"id":"W4411220058","doi":"10.1136/lupus-2024-001475","title":"Next generation sequencing analysis reveals complex genetic architecture of childhood-onset systemic lupus erythematosus","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute","keywords":"Medicine; Genetic architecture; Immunology; Computational biology; Biology","score_opus":0.050644427713338706,"score_gpt":0.32444168914351995,"score_spread":0.27379726143018124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411220058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977174,0.00039162955,0.0010389682,0.000051539766,0.0000025042045,0.0000041065873,0.0005128836,0.000013725148,0.0002673102],"genre_scores_gemma":[0.99730504,0.00034172207,0.0015381293,0.0000528617,0.000008194031,0.000005696364,0.0006012462,0.0000097077955,0.00013726811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996363,0.00009253123,0.000034944187,0.00011617566,0.00007680069,0.000043323704],"domain_scores_gemma":[0.9993266,0.00032424866,0.00022186762,0.000043095082,0.000042219253,0.000042155443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043622876,0.00022578609,0.00023542812,0.00076483405,0.00020900062,0.00039406703,0.00015970804,0.00027583583,0.0008967564],"category_scores_gemma":[0.0011990463,0.00011665052,0.00020138592,0.0007881051,0.00022100046,0.000112541136,0.00023118574,0.0002655314,0.000117932694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004241558,0.000039270035,0.8014863,0.00013684372,0.00041145715,0.0021992053,0.00045929715,0.0022111917,0.16366732,0.00038829038,0.0005019771,0.028074626],"study_design_scores_gemma":[0.000012763721,0.000057427023,0.9895683,0.000021515962,0.00009799373,0.0019875776,0.000122383,0.0016282089,0.0052523073,0.00029225516,0.0009523175,0.00000694113],"about_ca_topic_score_codex":0.0019437585,"about_ca_topic_score_gemma":0.00499002,"teacher_disagreement_score":0.0019437585,"about_ca_system_score_codex":0.00019666548,"about_ca_system_score_gemma":0.00016419798,"threshold_uncertainty_score":0.0038648844},"labels":[],"label_agreement":null},{"id":"W4411388952","doi":"10.1136/lupus-2025-001522","title":"Evaluation of MRI-based brain oxygen extraction fraction mapping in patients with systemic lupus erythematosus","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; Wuhan University; Zhongnan Hospital of Wuhan University; Natural Science Foundation of Hubei Province; National Natural Science Foundation of China","keywords":"Medicine; Amygdala; Caudate nucleus; Orbitofrontal cortex; Hippocampus; Grey matter; Voxel-based morphometry; Internal medicine; Montreal Cognitive Assessment; Voxel; Magnetic resonance imaging; Cardiology; Neuroscience; Cognition; Cognitive impairment; Psychiatry; Radiology; Psychology; Prefrontal cortex; White matter; Disease","score_opus":0.028785868299543264,"score_gpt":0.3371094679332498,"score_spread":0.30832359963370654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411388952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990564,0.00025561402,0.00019630762,0.000019019664,0.0000017871165,0.0000053122026,0.00006695803,0.0000076076008,0.0003909384],"genre_scores_gemma":[0.9996964,0.000054978387,0.00012969802,0.000008130197,0.0000037949162,0.0000026282353,0.00004572802,9.810495e-7,0.000057732086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999905,0.000027507112,0.000012511768,0.000025245725,0.000018737177,0.000010998024],"domain_scores_gemma":[0.99975294,0.000056397213,0.00012271582,0.000012866758,0.000027130662,0.000027882194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023028375,0.00034544992,0.0002387877,0.00047327313,0.0001704939,0.00026046566,0.00011417038,0.00029954637,0.0009370575],"category_scores_gemma":[0.00079819123,0.00008187364,0.00012485965,0.00023217025,0.00015093741,0.0001938572,0.00013393561,0.00014767278,0.00012389885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013630355,0.00009470558,0.9614023,0.000092051276,0.0001549837,0.0015497921,0.00021609939,0.00029325543,0.0201945,0.000039113736,0.00016429755,0.014435811],"study_design_scores_gemma":[0.000020641715,0.00028735702,0.99538547,0.000008724828,0.00004348703,0.0022922808,0.000120981065,0.0005246055,0.0011091884,0.00004248532,0.00016008751,0.000004692932],"about_ca_topic_score_codex":0.0006977445,"about_ca_topic_score_gemma":0.0008273405,"teacher_disagreement_score":0.0009370575,"about_ca_system_score_codex":0.000093610026,"about_ca_system_score_gemma":0.00007095293,"threshold_uncertainty_score":0.0031347275},"labels":[],"label_agreement":null},{"id":"W4411440670","doi":"10.1136/lupus-2024-001453","title":"Effects of dual-task exercises on cognitive status, disease activity and quality of life in childhood-onset systemic lupus erythematosus","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Quality of life (healthcare); Cognition; Physical therapy; Metabolic equivalent; Disease; Systemic lupus erythematosus; Intervention (counseling); McGill Pain Questionnaire; Internal medicine; Physical activity; Visual analogue scale; Cognitive impairment; Psychiatry","score_opus":0.01928294393670142,"score_gpt":0.33209610874143075,"score_spread":0.3128131648047293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411440670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983596,0.0012303827,0.000039081664,0.000026500553,0.000009831319,0.000014906575,0.00002981854,0.000003388682,0.00028629825],"genre_scores_gemma":[0.99890816,0.0004955989,0.00022049966,0.000030954645,0.000013029029,0.00003824729,0.000057670233,6.837272e-7,0.0002352132],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998436,0.000050976207,0.000019356652,0.000022869526,0.000025324736,0.000037964037],"domain_scores_gemma":[0.99974185,0.000057847417,0.00006440932,0.000009198828,0.0000176793,0.00010911536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025450462,0.0003812274,0.00048792732,0.00019810145,0.00017955982,0.00013757497,0.00012689231,0.00021006669,0.0010523971],"category_scores_gemma":[0.0004466203,0.000062989435,0.00039132952,0.0001070128,0.00009671801,0.000082936276,0.00025890634,0.00028394102,0.00007678822],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06684879,0.061396807,0.3395052,0.0037553294,0.0024148603,0.0009594152,0.00087738386,0.0016405701,0.03504285,0.00009148741,0.0012683657,0.486199],"study_design_scores_gemma":[0.0026270533,0.047198698,0.94426715,0.00020927073,0.000625231,0.00040764117,0.00022427097,0.0008029316,0.0024119727,0.000057143112,0.0011536231,0.000015048823],"about_ca_topic_score_codex":0.00077277236,"about_ca_topic_score_gemma":0.0018389898,"teacher_disagreement_score":0.0010523971,"about_ca_system_score_codex":0.000119742355,"about_ca_system_score_gemma":0.00012485166,"threshold_uncertainty_score":0.0035206676},"labels":[],"label_agreement":null},{"id":"W4412378800","doi":"10.1136/lupus-2025-001505","title":"Assessing grey matter structural alterations in systemic lupus erythematosus using synthetic MRI","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Grey matter; Pathology; Dermatology; Magnetic resonance imaging; Radiology; White matter","score_opus":0.03336735313331809,"score_gpt":0.3643871461166058,"score_spread":0.3310197929832877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412378800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991021,0.00023189819,0.0004053228,0.0000091124475,0.0000014888519,0.00000680476,0.000048083126,0.0000071779705,0.00018796904],"genre_scores_gemma":[0.99914837,0.0000889445,0.00058806676,0.000007408837,0.0000041135168,0.0000055974565,0.000082482926,0.0000012322439,0.000073670744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986565,0.000046469646,0.000020235537,0.000028506654,0.000026818243,0.000012229029],"domain_scores_gemma":[0.99958163,0.0000885428,0.00020275827,0.000036844434,0.000046917085,0.000043179483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045520868,0.00022817052,0.00014041744,0.00049568026,0.0000957643,0.0002557076,0.00011019543,0.00020416439,0.00094756216],"category_scores_gemma":[0.0009446177,0.00012734444,0.00010765013,0.00019187627,0.00017408343,0.00022119693,0.0002080808,0.00009203004,0.00015918139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016971902,0.00017796368,0.8975629,0.0002022201,0.00018025872,0.001192503,0.00030771794,0.0007848862,0.0756228,0.00007438758,0.0001599177,0.022037214],"study_design_scores_gemma":[0.00004072303,0.0014687391,0.9838284,0.000022273813,0.000062857005,0.006191583,0.00021607563,0.0022429433,0.005334036,0.00011657206,0.00046524394,0.0000105902],"about_ca_topic_score_codex":0.00020926085,"about_ca_topic_score_gemma":0.00031705777,"teacher_disagreement_score":0.00094756216,"about_ca_system_score_codex":0.000065142245,"about_ca_system_score_gemma":0.00007814165,"threshold_uncertainty_score":0.0031698942},"labels":[],"label_agreement":null},{"id":"W4413141419","doi":"10.1136/lupus-2025-001521","title":"Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Childhood Arthritis and Rheumatology Research Alliance; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Bristol-Myers Squibb Foundation; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; Centers for Disease Control and Prevention; Arthritis Foundation","keywords":"Medicine; Disease; Socioeconomic status; Systemic lupus erythematosus; Pediatrics; Internal medicine; Environmental health; Population","score_opus":0.015965316848017948,"score_gpt":0.2920846253628103,"score_spread":0.2761193085147924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413141419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905354,0.00015069912,0.00007503358,0.0000488142,0.0000014986156,0.0000041459434,0.00049811474,0.0000018360073,0.00016635629],"genre_scores_gemma":[0.9991478,0.00013194674,0.00011086124,0.000008092837,0.0000023352513,0.000008511216,0.00054192654,0.0000012299679,0.000047180096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941695,0.00018528133,0.00006566736,0.00010252621,0.000113540846,0.00011607697],"domain_scores_gemma":[0.99755776,0.00039050722,0.0015635872,0.000090669666,0.00013442153,0.00026315497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010979123,0.00021762887,0.00023711473,0.000712722,0.0003157185,0.00064344425,0.0002971777,0.0003007161,0.0017760965],"category_scores_gemma":[0.0043467013,0.00016507976,0.0004252821,0.0012830457,0.0002413911,0.0005477233,0.0007464717,0.0005578705,0.00019624943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034910496,0.000010313344,0.9989353,0.000006569141,0.000013281018,0.00004142151,0.00007725292,0.000080940525,0.000027465032,0.000019257943,0.000040607218,0.0007126795],"study_design_scores_gemma":[0.0000026823698,0.00004366247,0.999243,0.0000136277595,0.0000055853434,0.00019560213,0.00015746793,0.000209428,0.0000178412,0.000029704908,0.00007979485,0.0000016149191],"about_ca_topic_score_codex":0.008901774,"about_ca_topic_score_gemma":0.008433946,"teacher_disagreement_score":0.008901774,"about_ca_system_score_codex":0.00034918668,"about_ca_system_score_gemma":0.0004941659,"threshold_uncertainty_score":0.017699897},"labels":[],"label_agreement":null},{"id":"W4414444480","doi":"10.1136/lupus-2025-001595","title":"Towards a minimal core dataset for systemic lupus erythematosus studies","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; Queen Elizabeth II Health Sciences Centre; University of Calgary; Krembil Foundation; University of Toronto; McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Manchester Biomedical Research Centre; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute for Health and Care Research","keywords":"Core (optical fiber); Set (abstract data type); Systemic lupus erythematosus; Lupus erythematosus; Common core","score_opus":0.08169463425286401,"score_gpt":0.409934587069703,"score_spread":0.328239952816839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414444480","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058930818,0.006099579,0.5239196,0.018994382,0.0019269502,0.013936178,0.36183834,0.0028333317,0.011520976],"genre_scores_gemma":[0.09050695,0.0013299099,0.48695612,0.0031846277,0.00054194557,0.026712092,0.38965052,0.00034697665,0.0007707905],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9227739,0.04817802,0.014138926,0.0074252035,0.0060160584,0.0014679228],"domain_scores_gemma":[0.74656254,0.13811061,0.022211952,0.039526083,0.04562411,0.0079646995],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.096145555,0.0010020207,0.0027765976,0.009376738,0.0020691857,0.0064199823,0.007065582,0.0039180806,0.0065931506],"category_scores_gemma":[0.27943096,0.0013378774,0.0034620084,0.00897233,0.0012243825,0.005184024,0.012524092,0.00454933,0.0028891359],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002003604,0.0010363441,0.27405077,0.01518535,0.003121616,0.001200432,0.00403589,0.01630747,0.0031530422,0.07403637,0.3745822,0.2312869],"study_design_scores_gemma":[0.0017536565,0.001063334,0.1455661,0.018351147,0.0020187772,0.0012275007,0.004637247,0.06423678,0.002941579,0.15981784,0.59799236,0.00039371135],"about_ca_topic_score_codex":0.005683778,"about_ca_topic_score_gemma":0.006270586,"teacher_disagreement_score":0.9038544,"about_ca_system_score_codex":0.0033194954,"about_ca_system_score_gemma":0.011951932,"threshold_uncertainty_score":0.5084724},"labels":[],"label_agreement":null},{"id":"W4414925261","doi":"10.1136/lupus-2025-001725","title":"Impact of rural residence on clinical outcomes in SLE: a systematic review","year":2025,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Comparability; Rurality; Residence; Outreach; Rural area; Health care; Rural population; Rural health","score_opus":0.11066990671406848,"score_gpt":0.517629038409046,"score_spread":0.40695913169497744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414925261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031726642,0.9949586,0.00017426313,0.00035506205,0.00009619144,0.0002561343,0.0006970352,0.000008553808,0.0002815654],"genre_scores_gemma":[0.049190864,0.9483296,0.00060330296,0.00058984925,0.00009871623,0.0006747284,0.00040292548,0.000007640784,0.000102445614],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99299496,0.002794033,0.0023766665,0.0005908241,0.0010118805,0.00023164217],"domain_scores_gemma":[0.9629772,0.02717377,0.0070728343,0.0004361885,0.002013598,0.00032640187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007352631,0.0010695395,0.00630102,0.0067783077,0.00055699784,0.0024316518,0.0014997063,0.0013968339,0.0032713322],"category_scores_gemma":[0.04043858,0.0007193393,0.0065333545,0.009245313,0.0007463835,0.0017523051,0.0015229029,0.00094942556,0.00018154408],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018099639,0.0000115352805,0.0020418235,0.9655316,0.009767745,0.000075177806,0.00024456833,0.00009859447,0.00006197956,0.00013491351,0.0010226546,0.02082828],"study_design_scores_gemma":[0.00026495793,0.00019325502,0.012213884,0.88789254,0.08676473,0.00035809647,0.0005045885,0.00012435144,0.00010707003,0.0003107104,0.011226657,0.000039036295],"about_ca_topic_score_codex":0.010271491,"about_ca_topic_score_gemma":0.026786221,"teacher_disagreement_score":0.010271491,"about_ca_system_score_codex":0.0026778893,"about_ca_system_score_gemma":0.009692211,"threshold_uncertainty_score":0.038884938},"labels":[],"label_agreement":null},{"id":"W4417002228","doi":"10.1136/lupus-2025-001876","title":"New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16–17 October 2024","year":2025,"lang":"en","type":"article","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Chugai Pharmaceutical; EMD Serono; AstraZeneca","keywords":"Systemic lupus erythematosus; Clinical trial; Alternative medicine; General partnership; Drug development; Disease; Alliance","score_opus":0.10612738574604398,"score_gpt":0.4341227409207882,"score_spread":0.3279953551747442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002228","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026348087,0.019451689,0.0040219966,0.95011747,0.01783498,0.0015097801,0.0007531229,0.00013519957,0.0035409373],"genre_scores_gemma":[0.0670312,0.055151355,0.07225146,0.6895161,0.07258348,0.02089569,0.004325523,0.0007858439,0.01745926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.67637056,0.19498873,0.03048676,0.009601472,0.076909974,0.011642497],"domain_scores_gemma":[0.36136466,0.3505538,0.050448302,0.017408272,0.1344755,0.08574941],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5388743,0.0030905865,0.0029059034,0.005082346,0.0058409716,0.01808339,0.007838641,0.032828122,0.0053387447],"category_scores_gemma":[0.4480582,0.0029729216,0.004382996,0.006055108,0.007874847,0.014208065,0.022082068,0.03535273,0.0017076154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001173138,0.0007992396,0.007716255,0.0050927727,0.00034926334,0.0005494568,0.004005115,0.0010525403,0.0014083605,0.00876453,0.7599431,0.2091462],"study_design_scores_gemma":[0.0011766904,0.0009132623,0.01747528,0.009270989,0.00026897943,0.00028690603,0.0030117186,0.0016956248,0.0008290738,0.0066049458,0.95809036,0.00037617085],"about_ca_topic_score_codex":0.019188674,"about_ca_topic_score_gemma":0.03396448,"teacher_disagreement_score":0.5388743,"about_ca_system_score_codex":0.017435996,"about_ca_system_score_gemma":0.116308495,"threshold_uncertainty_score":0.5686501},"labels":[],"label_agreement":null}]}